<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Amitha Kalaichandran on Medium]]></title>
        <description><![CDATA[Stories by Amitha Kalaichandran on Medium]]></description>
        <link>https://medium.com/@amithakalaichandran?source=rss-f0aa9a2e29a0------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/2*TfGnk3BXfBZBWbfb6L0Z1A.png</url>
            <title>Stories by Amitha Kalaichandran on Medium</title>
            <link>https://medium.com/@amithakalaichandran?source=rss-f0aa9a2e29a0------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sun, 22 Nov 2026 19:49:03 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@amithakalaichandran/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[AI Has Quietly Become Part of Our Health System, and Companies Must Build Responsibly]]></title>
            <link>https://amithakalaichandran.medium.com/ai-has-quietly-become-part-of-our-health-system-and-companies-must-build-responsibly-ad7632912df1?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/ad7632912df1</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[artificial-intelligence]]></category>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[technology]]></category>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Sun, 28 Dec 2025 14:02:46 GMT</pubDate>
            <atom:updated>2025-12-28T14:05:05.611Z</atom:updated>
            <content:encoded><![CDATA[<p><em>Americans are already using AI to fill gaps in care. What comes next will shape trust, access, and outcomes.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ivTQErXpiq58O8x29JValQ.png" /><figcaption>EvraHealth — evrahealth.com</figcaption></figure><p>Artificial intelligence is already changing health care, in hospitals and where 99% of care and management happens: where we live, work, and play.</p><p>AI is already acting as informal health infrastructure. Physicians use tools such as <a href="https://949d6bce.streak-link.com/Cs2P2x18vPMJA1S1ugnVwUnU/https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12033599%2F">OpenEvidence</a> and <a href="https://949d6bce.streak-link.com/Cs2P2xtiYlCZ1t4FnwqFi95u/https%3A%2F%2Fblog.doximity.com%2Farticles%2Fcompete-learn-and-grow-with-our-clinical-case-challenge-library">Doximity</a> to synthesize rapidly evolving medical literature. AI can also reduce administrative burden through chart review and ambient documentation tools and is thus already embedded across the health ecosystem.</p><p>AI is also stepping into the space ‘between healthcare visits’ by default. So, we must build systems that are accurate, ethical, and worthy of public trust. People are <a href="https://949d6bce.streak-link.com/Cs2P2xtNjWRlo6nr-QcK1vls/https%3A%2F%2Fwww.nytimes.com%2F2025%2F11%2F16%2Fwell%2Fai-chatbot-doctors-health-care-advice.html">turning to chatbots</a> for health advice because the traditional system has left a vacuum. For better or worse, AI is filling a long-standing gap around health information, continuity, and access, even when <a href="https://949d6bce.streak-link.com/Cs2P2x58_KShByT8Cg965xKf/https%3A%2F%2Fwww.nytimes.com%2F2025%2F12%2F03%2Fwell%2Fmedical-records-chatbots.html">privacy guardrails are risky</a>.</p><p>As both a physician and a startup founder working at the intersection of AI and health, I see five forces shaping where this goes next. Together, they will determine whether AI becomes a force for healing, or another accelerant of inequity and mistrust in healthcare.</p><p><strong>First: AI health solutions must be capable of integrating a user’s different health needs.</strong></p><p>Focusing narrowly on a single condition — menopause, diabetes, weight loss — ignores the reality that most are managing multiple, overlapping health issues, either at once or over their lifetime. Diabetes during menopause, for example, is not the same as diabetes alone. The single biggest women’s health issue is heart disease: it kills <a href="https://949d6bce.streak-link.com/Cs2P2xxysg0r-8SoQQWyHYp9/https%3A%2F%2Fwww.heart.org%2F-%2Fmedia%2FPHD-Files-2%2FScience-News%2F2%2F2022-Heart-and-Stroke-Stat-Update%2F2022-Stat-Update-factsheet-Females-and-CVD.pdf">one woman a minute</a> in the U.S., and many women <a href="https://949d6bce.streak-link.com/Cs2P2x1ExEr7WFV-mA3ITUzf/https%3A%2F%2Fwww.henryford.com%2Fblog%2F2025%2F05%2Fwomen-ignore-signs-heart-attack">are not aware</a> of how cardiac disease symptoms differ between genders.</p><p>As well, solutions must meet people where there are now. Two moments crystalized this for me. The first came in 2019, in the back of a cab in Franklin County, New York, <a href="https://949d6bce.streak-link.com/Cs2P2xxOzhWbNOCEAgGwp9Eb/https%3A%2F%2Fdatacommons.org%2Fplace%2FgeoId%2F36033">one of the poorest regions in the state</a>. The driver, a 70-year-old man with diabetes, told me he was rationing insulin because he couldn’t afford it and couldn’t figure out how to stick to lifestyle changes his doctor recommended. What struck me wasn’t that he lacked a smartphone (he had one) but that he lacked clear, actionable guidance and sustained support. He wasn’t listening to biohacker podcasts. He simply wanted to live long enough to spend more time with his grandchildren.</p><p>The second moment came years later, while I was on book tour for <a href="https://949d6bce.streak-link.com/Cs2P2x1nJ5J2l9OXCAzq55YH/https%3A%2F%2Fonhealingbook.com%2F"><em>On Healing.</em></a> I spoke with more than 500 people across the country about health and what actually gets in the way of change. They shared that the wellness echo chamber served a narrow, privileged slice of the population and the problem wasn’t information. They wanted simplicity: clear steps, grounded in science and trust, tied to outcomes.</p><p><strong>Second: science is under attack, and rebuilding trust must be part of the work.</strong></p><p>Much of the anxiety around health AI stems from something deeper than technology: <a href="https://949d6bce.streak-link.com/Cs2P2x1U1Ov1SJR4QweoZgXx/https%3A%2F%2Fcarey.jhu.edu%2Farticles%2Famerican-health-care-policymakers-help-trust">mistrust,</a> often secondary to misaligned incentives for healthcare providers to provide treatment that is not always in the best interest of the patient. There are millions of Americans for whom the medical system has failed people who were rushed, overprescribed, or steered toward interventions they did not need. I experienced it personally myself in 2020 when a surgeon attempted to upsell me expensive surgery for my broken wrist when I only needed a cast (thankfully I could advocate for conservative management). <a href="https://949d6bce.streak-link.com/Cs2P2x59vV2yNeE_aw3ABIMC/https%3A%2F%2Fwww.wired.com%2Fstory%2Fthe-need-to-change-minds-about-why-doctors-change-their-minds%2F">Everyday Americans like Diane, whom I interviewed,</a> based in Asheville North Carolina, spoke to the same mistrust that led her and millions of Americans to seek alternative treatments, and heard versions of the same story across the country.</p><p>We have to hold two truths at once. Mistrust in the health care system is real and, in many cases, <em>earned.</em> That mistrust has increasingly spilled over into skepticism toward medicine and science as a whole. This is not a partisan problem. And this is <a href="https://949d6bce.streak-link.com/Cs2P2x5XV5CdMMOilQWZ7WNL/https%3A%2F%2Fwww.latimes.com%2Fopinion%2Fop-ed%2Fla-oe-kalaichandran-vaccination-anti-vax-20190605-story.html">not only about vaccines</a>.</p><p>Trust cannot be rebuilt through authority alone. It requires transparency, evidence, and accountability. That makes rigor in health AI non-negotiable. Foundational models, including those developed by companies like Anthropic and OpenAI, represent an extraordinary leap forward, but they are not designed to coach and guide people towards healthier behaviors; they can’t boil the ocean. <a href="https://949d6bce.streak-link.com/Cs2P2x52dtqpbBHieQLp7pmf/https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC10552880%2F">Hallucinations remain a real risk in health contexts</a>, where the cost of error is measured in lives.</p><p>To rebuilt trust, health AI solutions must be grounded in clinically validated data, transparent methods, and continuous evaluation. Safety in medicine has always required constraints, not scale alone.</p><p>Security and privacy are equally central to trust. The <a href="https://949d6bce.streak-link.com/Cs2P2x5g4CIt0TfowgBTU9og/https%3A%2F%2Fwww.hipaajournal.com%2F6-9-million-23andme-users-affected-by-data-breach%2F">recent 23andMe data breach</a> was a warning. Health data is among the most sensitive data we have. Without strong guardrails, trust collapses.</p><p>And the threat is not only domestic. China is <a href="https://949d6bce.streak-link.com/Cs2P2x5PD20mdZNqpQUoA0Xd/https%3A%2F%2Fwww.economist.com%2Fchina%2F2025%2F11%2F27%2Fdr-chatbot-is-popping-up-all-over-china">already deploying doctor chatbots at scale.</a> Health is wealth. Health is national security. Investing in building secure, science-based domestic health AI is strategic, and bipartisan support for innovation is crucial.</p><p><strong>Third: health AI must be researched like a public-health intervention.</strong></p><p>Most startups do not conduct independent research or test outcomes over time, and the ones that do rarely compare their offering to placebo or to a competitor.</p><p>Yet health AI demands that level of scrutiny. My colleagues and I recently released two research papers in preprint examining the state of AI in chronic disease: <a href="https://949d6bce.streak-link.com/Cs2P2xdNjbjsccRgDQ9phMrL/https%3A%2F%2Fpapers.ssrn.com%2Fsol3%2Fpapers.cfm%3Fabstract_id%3D5708362">one analyzing current use</a> and limitations, <a href="https://949d6bce.streak-link.com/Cs2P2xx9PQE0lV6btQ3QbjHz/https%3A%2F%2Fpapers.ssrn.com%2Fsol3%2Fpapers.cfm%3Fabstract_id%3D5715042">the other exploring how AI could support sustained behavior change</a>.</p><p>The message is simple: effectiveness cannot be assumed. If a product claims to improve health, it should be able to show <em>how</em>, for <em>whom</em>, and under what conditions. The recent efforts like <a href="https://949d6bce.streak-link.com/Cs2P2xloKJ6ktV2FvgJxtZWo/https%3A%2F%2Fwww.cms.gov%2Fpriorities%2Finnovation%2Finnovation-models%2Fmaha-elevate">MAHA Elevate</a> and <a href="https://949d6bce.streak-link.com/Cs2P2xpHBywcaLJsmwlPBtMx/https%3A%2F%2Fwww.cms.gov%2Fpriorities%2Finnovation%2Finnovation-models%2Faccess">CMS Access</a> place outcomes as central, and this is a good way to support efforts that are hype-free. High impact medical journals, which institute rigorous peer review, are an asset to the public and to health AI companies seeking to make a sustainable impact in population health.</p><p><strong>Fourth: global health cannot be an afterthought.</strong></p><p>AI makes it possible to think differently about scale. Health challenges do not stop at borders, and with <a href="https://949d6bce.streak-link.com/Cs2P2xp5eZRkXXr_HQpRBxSr/https%3A%2F%2Fwww.kff.org%2Fglobal-health-policy%2Fu-s-foreign-aid-freeze-dissolution-of-usaid-timeline-of-events%2F">cuts to global health initiatives</a> provides an opportunity for social enterprise to fill the gap. Our team has made it a mission to contribute to global health improvement through launching concurrently across countries across the developing and developed world. In places like India, <a href="https://949d6bce.streak-link.com/Cs2P2xp-vmJY0fo9iAm0DLPq/https%3A%2F%2Fdata.who.int%2Fcountries%2F356">where chronic disease burden is high</a> and mobile access is widespread, AI-enabled guidance can reach populations long excluded from continuous care. Building for multiple populations from the outset forces better science and exposes hidden assumptions.</p><p><strong>Finally: AI offers a once-in-a-generation opportunity for access and equity, if values are explicit.</strong></p><p>The recent government shutdown placed healthcare access at the core. AI will not fix the health system on its own. But it can widen the doorway with bipartisan support. That promise depends on the values embedded in these systems from the start. Design choices about what data to include and prioritize matter. For instance, our team has decided to exclude race and ethnicity in our intake forms. <a href="https://949d6bce.streak-link.com/Cs2P2xld3RetkU_IHAlfVKU2/https%3A%2F%2Fwww.aamc.org%2Fnews%2Fracism-not-race-drives-health-disparities">Race is not the cause of inequitable outcomes; racism and structural discrimination are</a>, and we’ve learned painful lessons around what happens when race is <a href="https://949d6bce.streak-link.com/Cs2P2xp0tK5MAieJjQ8BAQNT/https%3A%2F%2Fwww.wired.com%2Fstory%2Fai-bias-predict-death%2F">embedded in AI algorithms in healthcare</a>. Increasingly, evidence suggests that income constraints, lived experience, family history, and geography are more predictive of chronic disease risk than race alone. We’ve made <a href="https://949d6bce.streak-link.com/Cs2P2xxExBm6qsZj7Ai8jero/https%3A%2F%2Fevrahealth.com%2Fvision%2F">our values explicit</a>, and hope others will do the same.</p><p>As we make our New Year’s resolutions and look toward 2026, I’m reminded of a moment just before the pandemic began. In early 2020 — only a month before COVID reshaped daily life — I wrote about the <a href="https://949d6bce.streak-link.com/Cs2P2x1r63owECxaTQVFZsOw/https%3A%2F%2Fwww.nytimes.com%2F2020%2F01%2F07%2Fwell%2Flive%2Fnew-years-resolutions-health-fitness-coaching.html">importance of coaching for New Year’s resolutions.</a> I never would have imagined that within six years, it is conceivable that every person on the planet could have access, for the first time, to credible health guidance in their pocket: a science-backed, privacy-assured health companion to help them make better decisions, every day.</p><p>That future is not inevitable. It will depend on whether we choose rigor over hype, ethics over speed, and public good over short-term gain. But if we get it right, we won’t just be building better AI. We’ll be rebuilding trust in health itself, and making chronic disease less inevitable than it has ever been before, for every one of us.</p><p><em>Amitha Kalaichandran, MD, MHS is a physician, epidemiologist and founder of </em><a href="https://949d6bce.streak-link.com/Cs2P2xtLi79oECLBXAdx4Ig5/https%3A%2F%2Fevrahealth.com%2F"><em>Evra Health</em></a><em>, a science-based AI startup working to make chronic disease prevention and management accessible for all.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ad7632912df1" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Culture as a Product (Redux): Why On Running Succeeded]]></title>
            <link>https://amithakalaichandran.medium.com/culture-as-a-product-redux-why-on-running-succeeded-3f89691a25a8?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/3f89691a25a8</guid>
            <category><![CDATA[on-running]]></category>
            <category><![CDATA[running-shoes]]></category>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[startup-lessons]]></category>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Sun, 23 Mar 2025 21:22:55 GMT</pubDate>
            <atom:updated>2025-04-25T00:06:34.085Z</atom:updated>
            <content:encoded><![CDATA[<h3>The key omission from Part 1: “OPs as a startups biggest risk”</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*snOiymsPfCcREsNGXwJxpg.png" /><figcaption>The original founders of On Running. L-R: David Allemann, Caspar Coppetti, Olivier Bernhard</figcaption></figure><p>After publishing <a href="https://medium.com/@amithakalaichandran/why-we-must-view-culture-as-a-product-88d6a82a49b6"><em>Culture as a Produc</em></a><em>t</em> last Fall, an executive coach reached out and offered a powerful insight. While A players are a startups biggest competitive edge, and C players are its biggest threat (to success/growth), I had left out a key aspect of why C players pose such a risk to a company seeking market domination: Overly Political (OP) hires. He pointed out that the Venn diagram between C-players and OPs is close to a perfect overlap (imperfect because some C players are indeed less political, but get ousted quickly due to having no buffer for incompetence; some A players as OPs but may be held into account over time — see Robert Sutton’s <a href="https://chatelaine.com/living/asshole-survival-guide-robert-sutton/">work</a>) but is so risky to founders (especially CEOs) that it deserves its own paragraph (or two…), so I dedicated a new post to this idea. Indeed, OPs are not just cultural mismatches. In early-stage environments, they are existential risks.</p><p>This coach pointed me to the <em>Wallstreet Journal </em>bestseller, <a href="https://www.survivalofthesavvy.com/"><em>Survival of the Savvy</em></a><em> </em>(and shout out to Marty Seldman for an insightful exchange recently about some of the main points for startups, which I’ve adapted here) which every CEO (especially) and founder should read. I’ll say this again: Get. This. Book. As a CEO, feel free to look at the charts I’ve embedded in here, and the case study, but the CEO-specific chapter alone is worth the $14 purchase.</p><p><strong>Exhibit A: The Organizational Savvy Continuum</strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*zh7og_VAFtBC_3lsHItsfw.jpeg" /><figcaption>credit: Survival of the Savvy (Rick Brandon and Marty Seldman)</figcaption></figure><p>The book, and accompanying research on organizational deception, makes one thing clear: politics kills momentum. Momentum is the fuel startups need to succeed.</p><p><strong>Case Study: Susan (UP coached to be LP) and Jeannette (OP)<br></strong><em>Note that Bill Eddy may identify Jeannette as a ‘</em><a href="https://highconflictinstitute.com/high-conflict-strategies/negative-advocates-how-they-we-become-emotionally-hooked/"><em>hostile personality</em></a><em>’ (BPD traits) due to florid gossip and manipulation and the use of negative advocates (see part 1 of Culture as a Product). The case study below is one in which the UP was ‘coached to be an LP that could identify OPs and protect herself from them.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Uw9cv-adhbU9Ze7GgKyubA.jpeg" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*T-RoLPgEJGa56HGbNj5J0w.jpeg" /></figure><p>Note: Brandon/Seldman recommend similar strategies and scripts to <a href="https://www.psychologytoday.com/us/blog/5-types-people-who-can-ruin-your-life/201809/biff-4-ways-respond-hostile-comments">Bill Eddy</a>, but the approaches are complimentary. These are some examples OP C-players may use to sabotage A players with during leadership or manager conversations:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*sMFKrDUw2zYu7cSMwKrP9Q.jpeg" /></figure><p>Now how does this translate to startup success?</p><p>I’ll use the example of Nike as compared with a new player in the running shoe market: On Running. Why? Because in healthtech, we need an “On Running of Healthcare” (lets presume the conventional healthcare system is more like Nike…).</p><p>In large companies like Nike, politics can be absorbed. We can say the same about Amazon, Meta, and so forth (which I argued in the <a href="https://amithakalaichandran.medium.com/why-we-must-view-culture-as-a-product-88d6a82a49b6">first essay </a>— culture matters the most before market domination; then it’s a ‘nice to have’ and a competitive edge that may help the company succeed (especially as they launch new verticals) a bit more than it already is, and have better margins but is <em>less likely to totally sink a company </em>unless something very drastic occurs that has a major negative impact on the primary product offering).</p><p>Nike had close to 50 employees by the time it was beginning to scale in the 1970s. With robust margins and growing brand equity, even some dysfunction could be tolerated: they were <a href="https://stanfordmag.org/contents/the-force-behind-the-nike-empire">building a countercultur</a>e to the dominant culture. But this was ok, as there was limited competition in the running shoe market and no real race to the top. Later, with Michael Jordan on board, they owned the market — it was a wise step to appoint a celebrity ambassador after they created a product the market simply loved.</p><p>Now let us contrast it with a startup seeking to gain market share of a pool dominated by Nike (and Adidas/Reebok). Startups don’t have the luxury of owning the market or being a first-mover. They’re first trying to <em>prove product-market fit — they’re trying to simply exist!</em> They need every hire to move the needle on differentiation. That’s why On Running is such an important case study in cultural and strategic discipline.</p><p>On Running didn’t launch with a flashy campaign or an influencer rollout. There was near zero hype. I heard about this obscure Swiss company from a UK friend, but didn’t consider trying on shoes until another friend, working in the Emergency Room in New York in early 2020, mentioned that half of the ER docs wore them due to the long hours in those early months of the pandemic. The shoes provided support and their feet were less sore after sometimes 12–24 hour intense shifts. So: I bought a pair of “ONs” and loved them. I’ve purchased five pairs since, and I haven’t bought a pair of Nike running shoes since 2019: it’s a sticky product and everyone I know who owns a pair evangelizes them. Is there marketing? Sure, but it&#39;s icing on top of organic hype due to an excellent shoe. :)</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/950/1*0FSqNdJXEPJi1wxSikNiiA.png" /><figcaption>September 2021 — predicting On Running’s success in the public markets</figcaption></figure><p>On Running eventually brought Roger Federer on board, but only <em>after </em>the product was exceptional enough to warrant his interest. Their early team was tiny — just three co-founders and a handful of high-performing individuals in the first few years. Who were they?</p><p>1.Oliver Bernhard: former Swiss triathlete (who won the Ironman many times)who had the lived experience of ‘wanting a better shoe’. He wasn’t (and isn’t) a household name, so was never in the running (see what I did there ;) ) to be a brand ambassador, but perfect as a founder</p><p>2.David Alleman: brand strategy pro</p><p>3.Caspar Coppetti: seasoned operator (GTM)</p><p>Wait but who was the industrial designer/engineer? Oliver Bernhard! Crucially, when he retired from elite sports, he dabbled in prototypes (e.g. taking pieces of a garden hose glued to a shoe to simulate CloudTec). A ‘tech’ cofounder (or engineer) <em>wasn’t needed</em>: what was needed was someone who could identify the best possible early tech hire (engineer/industrial designer) to create what Bernhard wanted. That first eng hire had to convince Bernhard (and he did).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/300/1*h1Ycgawc5ssxsI6b2TE9IQ.jpeg" /><figcaption>Cloudtec — from a garden hose prototype!</figcaption></figure><p>On Running was obsessed. So they worked obsessively, with engineers/designers, in stealth for years. They weren’t trying to be 5% better than Nike. They were aiming to be 10x to 100x better. That required being heads-down and focused on building breakthrough technology (CloudTec), cutting-edge design, and elite performance testing. It required execution without politics: any friction was secondary to debate about building a better product, not sabotaging team or manager efforts. As well, Alleman and Coppetti were building the roadmap for growth and operations for deployment only *after* they had a product they could stand behind, one that was sticky and where users were starting to tell their friends to buy a pair of the shoes (and that’s when Federer came on board).</p><p>With those early hires on the design and tech side, while still in stealth and for that first year to 18 months out of stealth, they didn’t hire for politics. They hired for <em>excellence —</em> the best possible shoe designers, marketers, engineers, customer service reps (see also: <a href="https://www.renascence.io/journal/how-zappos-delivers-exceptional-customer-experience-cx">Zappos’ strategy)</a>, and so forth that they could afford.<em> </em>Intentional A player hires helped On Running build [the product] slow so they could then go [scale] fast.<em> </em>That’s the hidden genius of On Running’s early years. They delayed growth until the foundation was unshakable. And when they <em>did</em> scale, they did so with trust and competence, on the shoulders of an exceptional team, as their compass.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*HO6FGok0hJqK1gBA-d94zQ.jpeg" /><figcaption>Roger Federer — a key player to amplify an exceptional product</figcaption></figure><p>Federer became a co-founder to amplify what was <em>already excellent</em>, not to be a hypeman for a lackluster product. The core principle was clear: build something exceptional first. Everything else follows. Their IPO in 2021 was one I paid attention to, as an On Running customer, and they’ve grown exponentially since (they ‘<a href="https://en.wikipedia.org/wiki/Crossing_the_Chasm">crossed the chasm</a>’). Next time you’re at a gym take a look at how many are wearing On Running. Next time you’re simply walking around doing errands, look down. It’s Malcolm Gladwell’s <a href="https://www.theguardian.com/books/2000/apr/22/extract">Hush Puppies theory</a>, but modernized for 2025.</p><p>The major block to becoming the On Running of [X] industry, is what many startups get wrong: they overindex on Overly Political (OP) individuals (sometimes friends or those who pose less of an ego threat) who are <em>almost never</em> A-players (they’re often low B or C players) who keep their roles through manipulation, not merit. They withhold information, create drama, manage up, and sabotage [usually A-player] peers — all while appearing as agreeable takers (see <a href="https://hbr.org/2013/04/in-the-company-of-givers-and-takers">Adam Grant’s work</a>). They prioritize self-promotion over the success of the company (see the OP and LP continuum in Exhibit A above). The startup ecosystem, which moves fast and relies on trust, is <em>especially</em> vulnerable to these tactics.</p><p>The book highlights how OP individuals exploit a critical leadership blind spot. According to Seldman and Brandon, OPs:</p><ul><li><strong>Master words and buzzwords</strong>, creating a perception of intelligence.</li><li><strong>Manage impressions</strong>, ensuring they look good to those in power.</li><li><strong>Claim credit for wins</strong>, and plant seeds of blame in advance of losses.</li><li><strong>Track power dynamics</strong> closely, aligning with rising stars and avoiding risk.</li><li><strong>Sabotage quietly</strong>, using “calculated attacks” that sow doubt about others (this is the gossip, manipulation, and underhanded tactics described in “<a href="https://medium.com/@amithakalaichandran/why-we-must-view-culture-as-a-product-88d6a82a49b6">Culture as a Product</a>” and which Billy Eddy expands upon in his work.</li></ul><p>CEOs, in particular, are often targets of deception, so much so that an entire chapter is dedicated to assisting CEOs avoid this deception. In <em>Chapter 18: Expect Deception, Even (Especially) as a CEO</em> outlines, people in power become vulnerable due to self-deception and a desire to be seen in a positive light. Over time, they become isolated — surrounded by people who tell them what they want to hear. Their access to accurate information narrows. Their feedback loops degrade. And that creates a wide-open door for OP players to take hold: for a startup this impacts the competitive moat in two ways. The first is an inability to execute (product standards fall because A players leave or are silenced/not supported). The second is a delay shipping product (for the same reason).</p><p>These two things can sink a startup quickly because the first leads to a less sticky (and less exceptional) product. The second leads to an advantage for a competitor who can ship faster to the same target market. No amount of marketing can solve either of these issues — even an A player-filled marketing team (=marketing burn &amp; high CAC) cannot fix churn due to issues in the foundation (product, product, product). Great products lead to high customer retention and network effects. This wins, each time, as On Running clearly shows.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*6qlvpHMh95CB7_ZuQFCLDQ.jpeg" /><figcaption>Key chapter!</figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Y2yc0xzCe1nwx85syv7MYQ.jpeg" /><figcaption>Another page of this chapter</figcaption></figure><p>Indeed, this condition, which the authors in jest term “CEO Disease,” can lead to poor decision-making, erosion of culture, and the loss of top talent. Founders often don’t see the full impact until it’s too late — when the best people have left, deadlines have slipped, and the culture has turned sour.</p><p>That’s why On Running’s slow, deliberate hiring strategy worked. They protected their core. They didn’t just build a good culture — they <em>defended</em> it. They knew that even one low-trust hire in a 10-person team could sabotage the entire operation. So they prioritized high trust and high competence, staying firmly in the top-right of the Trust/Competence Grid (see below).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*EOjjX07w-YUJD-WaN0UgMA.jpeg" /><figcaption>Trust/Competence Grid: key to hiring and retaining high-performance teams (when used with the OP/LP spectrum). True A-players are in the top right quadrant — high competence/high trust, and minimal politics LP).</figcaption></figure><p>Compare that to the early Nike culture — which was innovative, but also more tolerant of internal competition, friction, and ambiguity. While Nike ultimately succeeded (thanks to an incredible brand and product-market fit), their path was messier. Arguably, if Nike were created today, using the same approach, it may not pass the seed or Series A round. Timing does, indeed matter, and competition in most industries in the 1960s/70s today is nothing like it is today (and it will only continue to become more intense).</p><p>On Running, by contrast, grew with <em>precision</em>. It’s no surprise they reached a multi-billion dollar valuation within a decade, with global traction and an iconic athlete-turned-co-founder-turned face of the company in Roger Federer.</p><p>Alright, so using the case of On Running, and the wisdom in <em>Survival of the Savvy</em>, what’s the lesson for startups who need to build an exceptional product that scales, with the agility to move quickly with little to no internal blockers (there are enough external blockers, namely time and competition)?</p><ol><li><strong>Avoid OP hires at all costs (or quickly dehire if identified).</strong> They don’t just slow you down — they destroy trust, sabotage A-players, and create blind spots for leadership. Review and understand the scripts and approaches in the book (i.e. the language OPs typically use) and respond using Bill Eddy’s <a href="https://www.psychologytoday.com/us/blog/5-types-people-who-can-ruin-your-life/201809/biff-4-ways-respond-hostile-comments">BIFF method</a> to refocus the conversation towards the product and company priorities.</li><li><strong>Expect deception as a CEO.</strong> Especially as your company grows, you will be flattered, misled, and manipulated, because you have power. Build systems to spot this early so incompetence doesn’t beget incompetence (or completely derail a team or the entire company).</li><li><strong>Prioritize trust <em>and</em> competence.</strong> The Trust/Competence Grid makes it clear: high-trust, high-competence people are your core team. Protect them.</li><li><strong>Don’t mistake performance theater for execution.</strong> Ask the hard questions. Ask for data/evidence (especially when faced with an OP ‘saboteur’). Reward substance over hype or distraction: startups can’t afford internal blockers (it places them at a disadvantage vs competitors who have engaged thoughtfully in culture and hiring).</li><li><strong>Train under political (UP)) A-players to become LPs that are mindful of OPs. </strong>This was the toughest lesson, I’m grateful that Seldman doubled down on this during our discussion recently, and it’s echoed explicitly in his book. <em>Most A player UPs want the work to speak for itself, but it never will. </em>They believe that competence will drown out the noise OPs often make. But building alliances and being wise to OP behavior (‘transforming into an LP’) allows that work to be executed effectively to move the company and metrics forward. Coaching UPs in this specific area is a worthwhile investment for the startup. The case study above, with Susan and Jeannette is especially helpful (Susan was a workshop client of Seldman and Brandon).</li><li><a href="https://www.nfx.com/post/the-3-person-unicorn-startup"><strong>When in doubt, be lean.</strong></a><strong> </strong>With the capabilities of AI now, lean teams (comprised of competent, engaged members) are as, if not more, positioned to be unicorns. A lean team of A player UP or LPs (with integrity, ethics), is more positioned for the long game and market domination over a clunky large team that leans towards OP, suffers from a lack of PMF and execution and gets overshadowed by a more agile competitor.</li></ol><p>Startups live and die by their people. On Running thrived because they stayed focused on what mattered — product, execution, and culture. They didn’t scale prematurely, they didn’t hire for politics, and they didn’t fall for theater. They built something exceptional — and they did it without the organizational drag of internal sabotage. They’ve scaled to a <a href="https://investors.on-running.com/stock-info/default.aspx">$14.97B</a> market cap (even with limited marketing and limited Instagram presence — the latter which I sort of wish they had earlier :) ). Oh and Federer? His decision to be a cofounder and brand ambassador of this once obscure running shoe brand has made him<a href="https://www.tennis365.com/tennis-news/roger-federers-investment-on-running-triple-tennis-earnings"> 3x more money</a> than tennis sponsorships or prizes did, and that trend is upwards.</p><p>Every tech founder should take note of ONs (as a case study) and OPs (as a risk). Because hype fades while culture compounds; the latter is key to crossing the chasm towards growth and market domination.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3f89691a25a8" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Can a startup emerge that explores Reality, Space-Time, and the Quantum Universe?]]></title>
            <link>https://amithakalaichandran.medium.com/can-a-startup-be-emerging-that-explores-reality-space-time-and-the-quantum-universe-e53499804e6b?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/e53499804e6b</guid>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Sat, 08 Feb 2025 02:52:59 GMT</pubDate>
            <atom:updated>2025-02-20T02:50:57.893Z</atom:updated>
            <content:encoded><![CDATA[<p><em>The idea that’s been on my mind the most…is not about health/health tech.</em></p><p>**NOTE: this was written before<a href="https://www.nature.com/articles/s41586-024-08404-x"> this study </a>was published &amp; before <a href="https://www.cnbc.com/2025/02/19/microsoft-reveals-its-first-quantum-computing-chip-the-majorana-1.html">this</a> announcement from Microsoft :)</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/822/1*_op2TrB-YdfpZqc8UY__2w.png" /></figure><p>As someone who has spent time conducting due diligence on emerging technologies, I’ve come across countless innovations that promise to disrupt industries and create seismic shifts in our daily lives. One area doesn’t seem to have the recognition it should: the realm of quantum computing and the specific role it will play in understanding our reality, debunking elements of classical physics, and so forth.</p><p>It may be the next frontier for innovation, one that could redefine our understanding of reality itself. The startup that positions itself to harness this to unlock new paradigms in space-time, reality, and even time manipulation, will be the ultimate unicorn (and the ultimate ‘zero to one’ in more ways than one). And why now: the confluence of advances in theoretical physics, quantum mechanics, spirituality, psychedelics, and generative A.I., combined with the power of quantum computing positions us to make novel discoveries in this specific area.</p><h4>Quantum Computing — what is it?</h4><p>Quantum computing represents a departure from classical computing, which relies on binary digits, or bits, to encode information as either a 0 or 1. Quantum computers, on the other hand, utilize qubits, which can exist simultaneously as both 0 and 1 due to the principle of superposition. Through quantum entanglement, qubits can become interconnected in ways that classical systems cannot replicate, allowing them to process massive amounts of information simultaneously. These properties grant quantum computers an almost magical ability to solve complex problems — problems that would take classical computers millennia to compute.</p><p>This has far-reaching implications for industries ranging from cryptography and pharmaceuticals (health link!) to financial modeling, not to mention modeling the likelihood of various endpoints in health (e.g. specific diseases…another health link!). But beyond the practical applications, quantum computing could become the key to answering humanity’s deepest questions about the nature of reality.</p><h4>Disrupting classical physics to ‘iterate’ on sense-based reality</h4><p>Classical physics, rooted in Newtonian mechanics, once dominated our understanding of the universe. However, with the advent of Einstein’s theory of relativity and the emergence of quantum mechanics, our perception of reality shifted dramatically. The classical view of a deterministic, predictable universe gave way to a probabilistic and interconnected cosmos, where particles can be in multiple states at once and affect one another instantaneously across vast distances.</p><p>Quantum computing is poised to bridge the gap between these seemingly incompatible views of reality. By simulating complex quantum systems, it could help us understand phenomena like wave-particle duality, the measurement problem, and the mysterious “collapse” of the wave function. As physicist John Wheeler suggested, reality itself might be “quantum participatory,” meaning that consciousness and observation play a role in shaping the universe. Quantum computers, with their ability to process and predict probabilistic outcomes, is now well-positioned to help scientists determine whether reality emerges from the quantum level or whether it exists independently of our perception.</p><p>This presents a tantalizing opportunity to back the foundational research that could lead to paradigm shifts in not only physics but also our perception of existence. Imagine a future where quantum simulations provide answers to questions about human consciousness, parallel universes, and the fundamental structure of the cosmos, which then helps guide action and have ‘influence’ on various outcomes...and make sense of stochastic reasoning (i.e. remove the very idea of ‘randomness’?)</p><h4>Space-Time and the Quantum Realm</h4><p>Einstein’s general theory of relativity describes space-time as a four-dimensional fabric that can be bent and warped by gravity. Quantum mechanics, on the other hand, focuses on the behavior of particles at the smallest scales. Reconciling these two frameworks has been one of the most significant challenges in physics, as the laws governing the very large (planets, stars, galaxies) often conflict with those governing the very small (subatomic particles). The quest for a unified theory of quantum gravity — one that explains how space-time behaves at the quantum level — has long eluded scientists.</p><p>Quantum computing could provide the computational power necessary to model and simulate these interactions at an unprecedented scale. Recent research suggests that space-time itself may have a quantum origin, potentially emerging from entangled networks of information. If this is the case, understanding and manipulating these networks could give us control over the very structure of space-time. Novel quantum algorithms could lead to breakthroughs in space exploration and teleportation technologies (SpaceX to TimeX…).</p><p>The implications are profound, especially as it relates to time. The companies that get there first will not just disrupt industries but will create entirely new ones.</p><h4>Time Manipulation</h4><p>Perhaps the most tantalizing possibility of quantum computing lies in its potential to “travel” through time, not in the conventional sense, but through the manipulation of information. Time, as we understand it, is a linear progression from past to future. However, in the quantum world, time may be more flexible, with the past, present, and future existing simultaneously — a concept known as block universe theory. This aligns with the idea of the “multiverse,” where all possible timelines coexist, and reality is a matter of which path we observe or influence.</p><p>Quantum computers could enable us to navigate this vast landscape of possibilities. Through quantum simulations, scientists could theoretically explore different timelines and predict outcomes with astonishing accuracy. The concept of “quantum retrocausality” — the idea that future events can influence the past — is already being explored in theoretical physics (and links fairly well to ideas like intuition and precognition). If quantum computing can harness this phenomenon, it could allow for limited forms of time manipulation, such as correcting errors in the past or optimizing decisions before they occur.</p><p>The company that succeed in developing quantum systems capable of modeling or influencing time will fundamentally redefine how we interact with reality itself.</p><h4>Ethical and Philosophical Implications</h4><p>As with any groundbreaking technology, quantum computing raises profound ethical and philosophical questions. What happens if we gain the ability to alter or manipulate time? Would we create paradoxes, such as the infamous “grandfather paradox,” where changing a past event prevents the present from occurring? Or would time manipulation be limited to small-scale corrections and optimizations?</p><p>Some of these elements, on a more experiential level, were explored in federally-funded government programs, such as the <a href="https://www.cia.gov/readingroom/docs/CIA-RDP96-00788R001700270006-0.pdf">Gateway Program</a>.</p><p>Moreover, if quantum computing enables us to simulate entire realities or alternate timelines, we must confront the question of what constitutes “real” experience (and perhaps answer <a href="https://www.youtube.com/watch?v=nnl6nY8YKHs">Bostrom’s question</a>…). If so, could quantum computers one day allow us to create or escape simulations at will?</p><p>Quantum computing is undeniably reshaping our understanding of the universe, making it the unicorn of technological development to help us understanding existence itself.</p><p>The companies that succeed in harnessing quantum computing will create and explore the mysteries of space-time and possibly even rewriting the rules of time and therefore innovation itself.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e53499804e6b" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Iterating on the Due Diligence Process in Healthtech VC]]></title>
            <link>https://amithakalaichandran.medium.com/iterating-on-the-due-diligence-process-in-healthtech-vc-f233c5b11f86?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/f233c5b11f86</guid>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Thu, 06 Feb 2025 18:42:07 GMT</pubDate>
            <atom:updated>2025-05-18T18:07:06.614Z</atom:updated>
            <content:encoded><![CDATA[<p><em>Due diligence as a VC — what are the special considerations for health tech?</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*NPZTAc6F_pgAwlRXpDRzRg.jpeg" /><figcaption>credit: Shutterstock (used with permission)</figcaption></figure><p>**************************************************************************<br>Note 1a: since first publishing this, <a href="https://www.bloomberg.com/news/articles/2025-02-18/hp-116-million-deal-for-humane-includes-ip-but-no-ai-pin-device">Humane AI</a>, despite not being a health tech company, would fall into this category: failed on each point, but used marketing/hype similarly to Theranos (i.e. matched closely to a legacy success, Apple). Humane AI was founded by former <em>managers</em> at Apple, neither of who were founders with exits; these managers co-opted the marketing strategy Apple used for decades to engineer a gut feeling, much as Elizabeth Holmes engineered it via the ‘CEO look’ Steve Jobs was known for.</p><p>Note 1b: Hype is different from a Scam. VCs are often paranoid about investing in scams, and assume hype is a signal for a scam. It isn&#39;t necessarily. Journalists also mix this up. Fair reporting means the public is better alerted to concerns that are ‘real’ vs not (e.g. misleading the public) vs those that are fairly normal in the world of business generally/tech specifically when it comes to marketing/branding where building excitement for the product is a normal goal.</p><p><strong><em>Hype</em></strong>: lots of buzz and excitement that often doesn’t really track with the product per se over time. Objectively obvious with high #s of signups but high market/PR spend as well, and typically high CAC and high churn. Usually not sticky and doesnt move beyond early adopters (i.e. it ‘doesn’t cross the chasm’). These companies usually burn out after money runs out. Key point: <em>Nothing fraudulent or intentionally misleading</em>. Advertising and branding often ‘appears’ misleading when taken at face value (product X will lead to Y; long apparent waitlists etc) but disclaimers are there for a reason and have only become more extensive over the years. Clubhouse was a hype-y company. Humane AI (pin) may be in this category as well. Google Glass…etc (so not restricted to startups).</p><p><strong><em>Scam:</em></strong> may or may not have hype but <em>always</em> has something fraudulent/intentionally misleading (inflated metrics or intentionally misrepresenting the contents or ingredients). Lots of examples in and outside of tech. Usually journalistic or legal investigations focus on the scams not the hype per se because hype in and of itself isn’t in the public’s interest — the public usually sorts through the hype over time anyway. Scams can only be proven through audits (financials), investigations (everything else). Where possible, VCs should audit financials before assuming one way or another that a startup is scam (vs hype). With A.I. this becomes easier to do. As with all research, data, and <em>triangulating</em> that data (i.e. not relying on self-report), matters.</p><p>When I think about the most successful companies in tech, there’s almost no hype at the beginning, and the hype follows after early adopters start telling their friends (for D2C; B2B would be different), so it’s like a slow build-up or a wave that peaks and usually stays there or decreases only slightly to a newly calibrated peak and steady state— the hype is organic in other words, and driven by the customer. In the U.S. alone, with 400m people, successful companies take a sizeable chunk of that market over the span of a year or so (exponential growth beyond early adopters). Facebook/Twitter/Apple/Amazon/Tesla even One Medical, and On Running are examples. For startups I’d include Oura and Maven. All have had slow buzz about an exceptional product that grows through this network effect, which legitimizes a high valuation (and eventual IPO). Some companies have hype at the very beginning and *do* end up having a product that matches this hype — Uber may be an example of this, and arguably Noom, and of course OpenAI/Anthropic/Perplexity, but this pattern is rare overall.</p><p>Note 2: Sam Altman’s ‘<a href="https://playbook.samaltman.com/">startup playbook’</a> is a core place to start, even for investors. However I’d place team ‘before’ idea — a bad team sinks a great idea, but a great team can iterate to find a great idea or pivot the business wisely with minimal internal friction. He also has some key thoughts re: competitors (distracting to hyperfocus on them), the importance of a great product etc.</p><p>Note 3: Financial services startup, Frank, founded by Charlie Javice, provides <a href="https://apnews.com/article/frank-founder-charlie-javice-charges-844589b428c50fe50ba720062bc5bc0b">another case study </a>where this framework may have helped prevent a sale to JP Morgan, who was [allegedly] defrauded due to fabricated user metrics (millions of users instead of under half a million users). This was an example of a ‘scam’ with no hype per se.</p><p>Note 4: Paul Graham’s essay ‘<a href="https://paulgraham.com/fr.html">How to Raise Money</a>’ is as key for founders as it is for investors. Especially this point (which links to my point 3 and 4): <em>“Fundraising is a chore for most founders, but some find it more interesting than working on their startup…The danger of fundraising is particularly acute for people who are good at it. It’s always fun to work on something you’re good at. If you’re one of these people, beware. Fundraising is not what will make your company successful. Listening to users complain about bugs in your software is what will make you successful. And the big danger of getting addicted to fundraising is not merely that you’ll spend too long on it or raise too much money. It’s that you’ll start to think of yourself as being already successful, and lose your taste for the schleps you need to undertake to actually be successful. Startups can be destroyed by this.</em></p><p><em>When I see a startup with young founders that is fabulously successful at fundraising, I mentally decrease my estimate of the probability that they’ll succeed. The press may be writing about them as if they’d been anointed as the next Google, but I’m thinking “this is going to end badly.”</em></p><p>Hope the notes above help answer some of Qs I’ve received. I’ll update these as new insights come in.</p><p>Ok onto the original framework!<br>***************************************************************************</p><p>During <a href="https://onhealingbook.com/">my book tour</a> so far, I’ve had several questions about the role of tech/startups and healthcare (and some of those early questions led to <a href="https://medium.com/@amithakalaichandran/why-we-must-view-culture-as-a-product-88d6a82a49b6">this post</a>). The book ends with the promising aspect of startups, Big Tech and legacy companies. Over the last few weeks, though, I’ve had more questions related to the venture capital/investment side of this, which isn&#39;t covered in my book at all. I’ve had so many questions in fact, that if I write another book, one chapter may be devoted to health VC and how to iterate on the standard due diligence process to avoid the classic <a href="https://medium.com/@mattimore/parable-the-emperor-has-no-clothes-ace63fef6eb8">Emperor with No Clothes</a> issue (VCs probably know if a bet is a good one, but groupthink/FOMO/hype can cloud this wisdom…leading to reliance on subject matter experts during the due diligence process). Recent SEC regulations make it crucial for venture firms to conduct prudent due diligence.</p><p>As I began dabbling in VC in 2022, I learned that my background in clinical medicine AND journalism were powerful reminders that triangulation and verification are <em>key</em> (‘trust, but verify, ideally with data and third parties’) aspects of due diligence.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*1xioumMBu_qbKMGQUkrTKw.jpeg" /><figcaption>credit: Shutterstock (used with permission)</figcaption></figure><p>Why? Because we need not look far (eg. <a href="https://www.investopedia.com/what-went-wrong-with-ftx-6828447">FTX </a>and <a href="https://www.investopedia.com/articles/investing/020116/theranos-fallen-unicorn.asp">Theranos</a>, and to a lesser degree <a href="https://www.investopedia.com/wework-doubts-its-own-survival-shares-crater-7574404">WeWork</a>) to see that hype and selling a good story <strong><em>can go a long way.</em></strong> <strong>Especially</strong> when it comes to health, the story can be a tear-jerker (we saw this with Theranos/Elizabeth Holmes) because face it: health, illness, death, and dying are emotional.</p><p>Here’s the rub: a big raise, even for a startup that fails fast, with all the ingredients for failure, <em>still makes money for the founders</em> (‘golden parachute’) — founders win either way *unless* they’re convicted of fraud, which is a tiny proportion of them (eg Bankman-Fried, Holmes). As such, it’s imperative to iterate on <em>how</em> VCs conduct due diligence and take a rational approach with a very tiny splash of something else (which I’ll get to: the last two points of the framework).</p><p>To help avoid being swayed, while doing due diligence for a solo healthtech-focused GP fund in 2023, I began compiling some ideas into a framework that goes beyond the traditional “product-market fit, traction, team” triad. <strong><em>My approach is more akin to how a doctor might make a diagnosis —</em></strong> except the diagnosis is binary: success or failure (i.e. a good bet or a bad one).</p><p>This is the skeleton framework (I expand on this below):</p><p><strong>1.Talent/size of founding team<br>2.Product IP vs. Market spend and any relevant early user feedback (be wary of no real IP and neutral or negative UX; IP/Market Spend correlation)<br>3.Hype (be wary of)<br>4.Rapid sequential raises/overblown valuations (be wary/ask why)<br>5.Culture red flags (retention as only one aspect)<br>6.Absence of key roles/absence of internal auditing (ability to trust the data ie internal validity of the reported data provided to investors)<br>7.Gut Feeling<br>8.Time</strong></p><p>The goal is to help steer back to the ‘rational’ and avoid the pitfalls that faced FTX, Theranos (both on the extreme end), and others on the less extreme end (e.g WeWork, but also more recently <a href="https://www.healthcarehuddle.com/p/why-forward-health-failed-lessons-for-tech-driven-primary-care">Forward Health</a>).</p><p>I used this framework for <strong><em>every single health tech startup</em></strong> that pitched me in 2023. Most didn’t pass the first two to three points. Two passed all 6 points but not the 7th/8th. Only one of them passed all 8, for me (then it was up to the GP).</p><p>This framework may <em>not</em> always lead to an immediate ‘yes’ or a ‘no’ to invest, but it <em>does</em> help nudge triangulation (seeking more data, verifying that data). It can lead as much to ‘finding a great investment’ to ‘avoiding a disastrous/legally fraught investment.’ I <strong><em>still use</em></strong> this framework when a VC colleague asks for my input on an investment.</p><p>To ground the framework in real examples, I’ve pointed to common patterns observed across multiple tech/healthtech companies and past high-profile failures such as Theranos and FTX and, to a lesser degree, Forward Health, Babylon Health, and WeWork.</p><p>I’ve listed these points *in order* for a reason (if the startup fails at point 1 there&#39;s no need to head to point 2 for instance — saves time and energy!). In general, I’ll make the decision ‘no’ once I reach the point number where the startup falls short, but for the sake of completeness (and to provide comprehensive feedback to the partners), I generally go through all 7–8 points for every company.</p><p>Also, you’ll see that the<strong><em> ‘market size’ isn&#39;t on the list</em></strong>. Market size for health, wellness, longevity, etc is huge, and growing. The market size for financial startups/crypto is similarly huge, and growing. It doesn&#39;t matter how huge it is — what matters more is whether the startup has a good chance of gaining market share of a huge market. <em>This one point doesn’t matter for most startups in healthtech — the market is big, and we get it!</em></p><p>Note: the list isn’t perfectly written or formatted because it was not originally an article or a blog post — it’s simply a set of notes I’ve used for awhile now that may lead to a mindful pause, so to speak, and iterates on the most common and imperfect framework for due diligence in venture capital. I’ve fleshed out the points with examples for clarity.</p><p><strong>1.How talented (<em>and large</em>) is the founding team?</strong></p><p>Most VCs do background checks/due diligence on the CEO but not the founding team. It&#39;s best to look at each founder closely, and ideally interview them with a subject matter expert/peer in the industry (if the VC doesn’t have the expertise) because most CEOs liaise closely with their cofounders on all decisions</p><p>For the CEO especially — has there been a notable exit? If not, do they have special skills/talents/experience, ie the top 5%? (eg the Musks/Jobs/Bezos of the world). Being great at raising money is a good thing (but note Paul Graham’s note above) but even more important is being bullish for A player talent (seeking them, hiring them, giving them the resources they need to deliver results, and retaining them).</p><p>Have the other founders ‘earned’ their spot as founders? Are they in the top 10–15% of what they do? And/or have they had notable exits? What about managerial/leadership training and experience (this question is less important but a bonus if the first two are met)?</p><p><strong><em>How many</em></strong> other founders are there? (a large founding team can slow down/impact key decision-making)</p><ul><li>size matters: in rare cases (eg Anthropic) a large founding team works because they’re all A players from a successful competitor. In most cases 2–3 founders are optimal (too many decision makers slows down progress, leads to infighting and other issues)</li><li>***<em>this is an underrated question</em> because B or C player founders don’t scale great companies primarily due to talent issues. Only <a href="https://x.com/founderspodcast/status/1665442439715225600?s=46&amp;t=PK-vWojaLurY6eXl341Thw">A player founders</a> are able to both recognize <em>and</em> retain A player talent (due to ego, perceived territorial elements etc — this links to culture and a deeper dive on this is <a href="https://medium.com/@amithakalaichandran/why-we-must-view-culture-as-a-product-88d6a82a49b6">here</a>). Musk, Jobs, and Bezos are all A player repeat founders that retained A player talent, scaled and succeeded.</li></ul><p><strong>2.Product: IP (Theranos example)</strong></p><p><strong><em>(2a) IP matters as much as product-market fit</em></strong></p><p>What “is” the product? Walk through it, ask ‘dumb’ questions, imagine the user/customer ‘journey.’</p><p>Does the product ‘depend’ on a third party (eg for processing, for facilities)? This is a higher risk bet (eg Theranos used a 3rd party analyzer for labwork), but sometimes a necessary intermediate step (e.g. Mac using intel chips).</p><p>Savvy design or UI is less important vs <em>real IP </em>(esp proprietary AI algorithms). This was also an issue with Theranos — design elements like a flashy website, futuristic offices, to even how the founder dressed show the influence of design.</p><p>Be very direct: What <strong>‘is’ </strong>the IP here? What makes this *truly* different than your competitors?</p><p>The failure of <a href="https://www.wired.com/story/babylon-health-warning-ai-unicorns/#:~:text=The%20reason%20companies%20like%20Babylon,patients%20requires%20thoughtfulness%20and%20context.">Babylon Health</a> for instance was one of overselling ‘proprietary AI.’ In 2025, specifically for any company claiming ‘proprietary AI,’ in healthtech, we can compare it with the next best user alternative, which is ChatGPT. ChatGPT today <a href="https://www.nytimes.com/2024/11/17/health/chatgpt-ai-doctors-diagnosis.html">can best </a>most physicians in diagnosis (recent research shows this), and is very good at incorporating clinical guidelines and <a href="https://lifestylemedicine.org/">lifestyle medicine </a>advice. The updated models will only be better at both diagnosis and preventative care/guidance.</p><p>Rephrasing the question specifically for AI-heavy IP: <em>is it 10–100x better than ChatGPT?</em></p><p><strong><em>(2b) The users ARE the marketing &amp; PR team (at first, through Series B, and sometimes to C at least)</em></strong></p><p>To rephrase <a href="https://www.youtube.com/watch?v=12D8zEdOPYo">Kevin Hale </a>(YCs) brilliant point, from way back in 2014 (!) about high market spend: <a href="https://www.threads.net/@startuparchive_/post/DGD1uJaC2Gq?xmt=AQGzrirTSSCy8a1qzX9vBv61WhO7CbkLKIp7PcKJS75aKA">“marketing is the tax you pay because you haven’t made your product remarkable…word of mouth growth is how a lot of the great companies grow.”</a> Your marketing and PR teams, in other words, should be <em>tiny: </em>social media management is a good spot to invest in for instance, but not ads or billboards. Hiring one publicist, perhaps on a fractional basis, to hire inbound media requests (especially crisis PR items) is helpful, but save the agency hire for Series B/C.</p><p>The marketing and PR team should be the company’s first 100/1000/10000 customers! Using a sourdough analogy: that’s the product ‘starter.’ A solid marketing &amp; PR team brought in later (eg Series B/C) simply <em>amplifie</em>s this so it simply grows and sustains itself over time.</p><p>How do users really feel about the product? If it’s a great product, you’ll probably hear about it <em>organically, in an enthusiastic way, often</em>. I would also include here that VCs should check forums like Reddit for ‘user experience’ feedback regularly. Redditors are highly engaged and due to the anonymity, are more likely to share honest feedback (good and bad).</p><p>The ‘feature’ of a product is its UX, and, indeed, the most reliable way to scale is not through formal marketing but simply through <em>word of mouth growth</em> (i.e. ‘the product is *so amazing* that I’m telling everyone to get it’).<em> </em>A proxy for good word of mouth growth is online organic praise/discussion of the product (Reddit, X, etc). <em>The Reddit principle applies less often to seed stage companies</em> that have few users, but it’s notable, and a good sign, if seed companies have highly engaged happy users that share often online. One company I pushed forward at seed stage in 2023 had a highly engaged and dynamic Reddit community praising a health tech product and its impact on their lives. This was a helpful data point.</p><p>To rephrase Kevin Hale again: the biggest companies today (Apple, Google, Twitter/X, Tesla, Amazon) began as startups that didn’t spend funding on marketing early on. Ad-spend was allocated <em>wisely</em> (e.g. Apple’s Think Different campaigns) to simply amplify organic growth to reach the edges of the market only once the product was 100x better than the competitor’s: IP should be inversely proportional to market spend (high market spend early on often signals a bad product that isn’t growing; low market spend early on often signals a good product growing organically)</p><p><em>Great IP 1/∝ Market spend</em></p><p>Why Theranos raised money: they were vague about their IP and sold a story (via marketing and PR) <em>very well</em> to <em>distract from</em> <em>not having IP</em>, all which leads to the next point…<strong><em>hype.</em></strong></p><p><strong>3.FTX example (hype)</strong></p><p>FTX disproportionately relied on hype/celebrity endorsements to ‘<a href="https://www.scribbr.com/fallacies/appeal-to-authority-fallacy/">appeal to authority</a>’. Celebrity endorsements can be powerful marketing tools, because celebrities are aspirational. Yet, without product quality and operational excellence, they risk being distractions. Did most of the celebrities chosen have expertise or experience in crypto? No. FTX employed celebrity influencer <em>marketing </em>(there’s the marketing bit again)<em> </em>to disguise not having a great product.</p><p>When it comes to healthtech: the authority should NOT be celebrities (or at least not ‘just’ celebrities), but rather the scientific community/physicians (conventional MDs), health policy experts, epidemiologists, etc who are respected for their clinical, scientific and research acumen <em>as well as</em> their ability to be a ‘visionary’/pioneering innovator (where is healthcare headed to ‘next’?). Note: <em>both elements are needed </em>(many leading health experts, especially in academic settings or legacy institutions have antiquated approaches to healthcare). <strong><em>Look to the founding team here, and the scientific/medical advisory board for clues.</em></strong></p><p>Often I’d see small companies point to 2–3 celebrities as ‘endorsers’ but it’s not terribly difficult to obtain these. Celebrities are friends with other celebrities, so word of mouth about an ‘exciting investment opportunity’ can spread. An investment can be as tiny as $500, with a disproportionately large equity stake or advisory role if the celebrity agrees to be featured in a pitch deck for instance (and this is common/I’ve seen this in decks).</p><p>It’s increasingly more common for a founder to be a celebrity themselves (e.g. lifestyle/fitness companies founded by athletes; several celeb-backed makeup and alcohol brands) — again: access. This was a key part of FTX — excessive celebrity endorsements, which helped market the company, but the celebrities themselves were not clear how FTX ‘worked’ (which then became their defense).</p><p><strong><em>This can also include access to influential individuals either within regulatory agencies, or who have power over those agencies.</em></strong> This was clear with Theranos, and why Holmes’ board was stacked with influential individuals with a track record in government and policy who could potentially have sway with government agencies (simply because: ‘we like doing business with our friends’ and ‘we trust who our friends endorse’).</p><p>When does hype work? When the IP is reliable, with a trusted market. Think: Apple’s launch events. These work purely because the anticipation is consistent year after year (or increasingly quarter after quarter), and users are accustomed to the product living up to the hype (i.e. the IP is reliable).</p><p><strong>4.[for Series A, B, C specifically] Valuation &amp; Growth.<br></strong>When companies overemphasize their valuation and growth, <em>without substantiating it through investor-dictated milestones</em>, it can signal trouble. Forward Health failed late in the funding cycle (Series E) for instance, so it can occur at any time and it’s easy to miss.</p><p><strong><em>For *any* startup raising very soon after a previous raise, ask founders:</em></strong></p><p>Were there issues with releasing the previous tranches (were milestones not met for growth to allow for timely tranch funding release?)?</p><p><strong><em>If the answer to this is vague, ask :</em></strong></p><p>Were there external signals of poor growth — eg key partnerships dropped, sudden high marketing spend, referral incentives, quick partnership agreements with low impact on growth, media reports of product issues that impacted growth, users switching to competitors at a high rate, high apparent CAC/Customer Acquisition Cost?</p><p>Historically, as we saw with examples like WeWork, companies that over-rely on free memberships or heavy user incentives often face long-term retention issues. Other companies fail due to an issue with a key partner driving user growth, and so forth. Still, others fail due to a media report or in-depth investigation (e.g. Theranos).</p><p>Current investors <strong><em>will not</em></strong> typically openly disclose if tranches are being withheld due to growth issues/milestones not being met.</p><p>High valuations often mask internal dysfunction, especially in companies that haven’t met their core KPIs, but usually very few (e.g. current investors) are privy to this information. So, look for other signs. If previous lead investors are <em>excited</em> to share more publically, and vet the valuation, that can be a good sign. Sometimes founders themselves will share that the valuation and new raise was at the <em>recommendation</em> of an early lead investor — this is helpful information.</p><p><strong><em>Then ask:</em></strong><br>Is this a down round disguised as an up round? Why or why not? [note that current investors may support this as a down round label can be perilous for current investors]</p><p>Is this an extension round disguised as an up round? Why or why not? This matters more for media/PR spin. A Series extension can sometimes signal money mismanagement and is rarely a positive sign indicating growth.</p><p><strong><em>Key question if there are signs of funding mismanagement: is anything in place to fix this/a contingency for the next round eg. hiring a CFO and ideally also a third-party audit?</em></strong></p><p><strong>5.</strong><a href="https://medium.com/@amithakalaichandran/why-we-must-view-culture-as-a-product-88d6a82a49b6"><strong>Culture is a second product</strong></a><strong> (link to my Medium analysis</strong><a href="https://medium.com/@amithakalaichandran/why-we-must-view-culture-as-a-product-88d6a82a49b6"><strong> here</strong></a><strong>)</strong></p><p>Many startup failures are linked to having too few A players especially at the founder or early employee level — see also point 1.</p><p>As a VC, checking ‘culture’ is tough, &amp; retention is only part of it (in a tough job market especially, it’s not a valid marker). Glassdoor reviews <em>aren’t helpful</em> (usually employees are warned they’d be sued/identities can be disclosed; usually only the most disgruntled employees dare post etc). Similar to Google Reviews, an absence of bad reviews means very little, and myriad good reviews, in close proximity to one another, also signal very little. Negative reviews, if spread apart over time from multiple users, are a helpful data point, but not on their own useful without further information and triangulation.</p><p>Reddit is very helpful for <strong><em>product feedback</em></strong> from users (see point 2), and rarely helpful for employee feedback (but often more helpful than Glassdoor).</p><p>The only real way to assess culture, which is linked to performance, is to have anonymous discussions <em>with employees (and if possible, former employees, who are usually more honest)</em>. <strong><em>Due diligence helps with this,</em></strong> but not every VC takes the time to search through LinkedIn to ask these questions (most rely on their VC network or word of mouth).<strong><em> Similar to doing a reference check on an employee, I’ve always called former employees as part of due diligence on a startup: most will be honest</em></strong>.</p><p>If the individual in question has a track record of success/is an A player and/or already swiped up by a competitor it’s an even more trustworthy source.</p><p>One great Q to ask <strong><em>current </em></strong>employees, borrowed from Adam Grant: is: <em>“What happens here that doesn&#39;t happen elsewhere”</em> (and simply wait for the response).</p><p>One great Q to ask <strong><em>former </em></strong>employees, in a way that avoids placing them in a position to disparage their former company or risk divulging IP: <em>“Would you personally invest in this company, knowing what you know now?”</em> and <em>“Let’s imagine 3–5 years into the future and this company has failed, what was the most likely reason?” </em>[this question is especially helpful because it sheds light on product weaknesses/IP weaknesses, culture, and ethics eg flagging early FTX/Theranos/Babylon Health types].</p><p>As it relates to culture and HR: Are key roles unnecessarily consolidated that shouldn’t be after a seed round? (eg HR with COO; CFO with CEO)? <em>Why might the founders be incentivized not to have an HR lead?</em></p><p>This leads to…</p><p><strong>6.Note the absence of other key roles that provide oversight/internal audits [for Series A, B] — WeWork example</strong></p><p>An experienced C-suite team (esp with experience in larger industries/corporations — Aetna, CVS etc) can do wonders for a healthtech startup that’s showing great signs of growth but needs <em>stronger direction and leadership.</em></p><p>CFO is a role that can be helpful early, especially if it is a non-founder role (as they’re less likely to inflate numbers/fiduciary duty). Key question: <em>Why might the founders be incentivized not to have a CFO?</em></p><p>What other oversights/audits are in place to guard against over-inflating metrics (growth eg conversion/purchases and financials)? <em>Why might the founders be incentivized not to have oversights and audits?</em></p><p>[<a href="https://www.investopedia.com/wework-doubts-its-own-survival-shares-crater-7574404">WeWork</a> is a helpful example of a lack of oversights/audits.<a href="https://finance.yahoo.com/news/javice-wharton-pal-says-created-141848282.html"> Frank</a>, and the indictment of Charlie Javice, who fabricated user growth metrics to allegedly defraud JP Morgan, is another recent example of why third party audits are critical]</p><p><strong>7.Trust your Gut Feeling</strong><br>I <a href="https://thewalrus.ca/how-much-of-a-doctors-diagnosis-is-gut-feeling/">wrote about gut feelings</a> as they relate to medical diagnoses way back in 2018. As much as points 1 through 6 cover logic and rationality, gut feelings and intuition <em>matter,</em> but there’s a reason why this point is all the way at the end.</p><p>Even VCs with decades of experience and a track record of great bets, <em>ignore</em> their gut from time to time because the hype and FOMO is strong! :) Reports of FTX and Theranos, after the fact, point to this.</p><p>At the end of the day, it’s a gamble that can end up costing millions of *other people’s money* on top of, in extreme cases, fraud or misleading investors (eg FTX and Theranos) and legal costs.</p><p><strong><em>The best advice I have here is to check in with yourself:</em></strong></p><p>Does something ‘feel’ off? Does something ‘seem’ overhyped?</p><p>Does the founder ‘seem’ a bit unethical?</p><p>Does the feeling or pitch ‘remind you’ of a company that ended up being fraudulent, or simply failing miserably after a large valuation due to culture, product issues, lack of sustainable growth etc?</p><p>And so forth. Be aware that founders may try to ‘engineer a gut feeling’ by ‘matching’ closely with an established success via marketing and hype (e.g. copying e.g. how Holmes’ copied Steve Jobs’ ‘CEO look’ at Apple; how companies may copy marketing elements).</p><p>One, now publicly traded, company did this <em>well</em>: <a href="https://www.on.com/en-us">On Running</a>. They appeared to use Apple’s marketing and brand strategy for their website and physical stores,<em> but they could</em>, because they could boast a phenomenonal founding team and IP (‘cloud technology’ coupled with beautiful design) — with a great product and team, marketing just amplified what was happening organically. As an organic user who would happily evangelize On Running whenever I could, I purchased stock the moment they went public in Sept 2020, and am glad I did :) I simply LOVE that company! {proof <a href="https://amithakalaichandran.medium.com/culture-as-a-product-redux-why-on-running-succeeded-3f89691a25a8">here</a>}.</p><p>What’s the best way to get ‘better’ at trusting your gut? Test it! With public stocks, with people, with opportunities — is it calibrated well or do your biases interfere?</p><p>This brings me to the very last point…</p><p><strong>8.Time</strong><br>Take your time. Don’t jump at investing. Check points 1–6 diligently and rigorously. Score the company accordingly.</p><p>Then spend time on point 7 <em>only,</em> and simply sit with it (with time, point 8).</p><p>Give it a week, a month…whatever it takes. If it takes too long, it’s likely a no, or a ‘not now.’</p><p>Ignore the pressure you’ll undoubtedly get from founders — it’s not your money after all. <strong><em>It’s a bet</em></strong>, nothing more, nothing less. They will push for you to bet investors’ cash on them because they win regardless (see paragraph 4 of this post) — from experience this isn’t pleasant (and can end up with an unnecessary number of followups…in once case I heard from a startup an entire year later, persistently!) so be prepared.</p><p>Discuss the investment opportunity with <em>experts</em>, continue your <em>due diligence calls</em> (you can never do too many), and ask <em>tough questions</em>. While it&#39;s natural to confer with your VC colleagues about ‘whether they’ll invest,’ avoid groupthink — in fact <strong><em>try to engage</em></strong> your VC friends <em>honestly</em> on points 1–6 as well because they may have intel you don’t and vice versa (and you may help them avoid a bad investment or perhaps double down on a great one).</p><p>Lastly, if it remains a real toss-up: consider reducing risk in other ways (e.g. liquidation preferences to ensure the investment is paid back before funds go to founders) — if a founder pushes back on this, it’s notable. But really…why invest if it requires this much hedging?</p><p>From FTX’s rapid collapse to Theranos and WeWork, to even Babylon Health, the lessons remain clear: no amount of hype (especially be wary of <a href="https://www.hollywoodreporter.com/news/general-news/elizabeth-holmes-speaks-prison-theranos-1236134432/">tricksters</a>) can replace the fundamentals of a strong IP-based product and promising (and triangulated/verified) growth metrics, to help make a decision to invest (or…not). Good luck!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f233c5b11f86" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why We Must View Culture as a ‘Product’: How Startup Success Post Series A/B is Shaped through…]]></title>
            <link>https://amithakalaichandran.medium.com/why-we-must-view-culture-as-a-product-88d6a82a49b6?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/88d6a82a49b6</guid>
            <category><![CDATA[healthtech]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[technology]]></category>
            <category><![CDATA[tech]]></category>
            <category><![CDATA[startup]]></category>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Thu, 07 Nov 2024 01:23:37 GMT</pubDate>
            <atom:updated>2025-03-23T23:08:04.848Z</atom:updated>
            <content:encoded><![CDATA[<h3>Why We Must View Culture as a ‘Product’: How Startup Success Post Series A/B is Shaped through Fostering High Performance</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*VG8vLf27hp5RKWRJ6h5xVA.png" /><figcaption>Jawbone — one of the first health tech products (tracking steps and sleep)</figcaption></figure><p>In my forthcoming book <a href="https://onhealingbook.com/"><em>On Healing</em></a>, one chapter covers the issue of hospital workplace culture, and the link to both patient outcomes and provider (doctors and nurses for instance) burnout. Indeed, the health of our workplaces is a key aspect of both healing and well-being (as well as longevity/how long we live and healthspan/the quality of those years lived).</p><p>Several early readers of the book, knowing of my work in health tech (startups and Big Tech), have asked why I didn’t cover the same concept in the world of tech, especially given the rise of startups as well as Big Tech (Google, Apple, Amazon) in healthcare. The simple answer: I needed to focus on one core example. However, the principles still apply widely to a variety of organizations and companies, not simply hospitals. In a hospital setting, a toxic culture can trickle down to impact provider retention, something we’ve seen in spades with the COVID-19 pandemic. It can also impact healthcare outcomes (<a href="https://www.nytimes.com/2019/05/30/us/children-heart-surgery-takeaways.html">Ellen Gabler’s investigative work </a>is described in my book, as is Amy Edmondson’s <a href="https://accelerate.uofuhealth.utah.edu/improvement/psychological-safety-for-teams">pioneering work on psychological safety</a> and medical error).</p><p>In an attempt to quell these early readers, we can dive into the core elements of culture that link to tech startups (including, but not restricted to, healthtech startups), something I was recently asked to do more formally for a small pre-Seed funded startup (~8 employees) facing challenges with shipping a hardware product (MVP), where the CEO was aware of low morale playing a role. Their task: could I help identify the core aspects governing this low morale, and could it be fixed? What resulted was a detailed report, of which some elements are drilled down here as a framework for approaching culture, one that focuses on what matters, and ignores the noise, to quickly identify blocks to growth/shipping product efficiently.</p><p>As a physician who consults in health tech, I’ve long wondered if more health tech startups would reach success if culture was considered a ‘product,’; not the primary product, but as a secondary product that can make the difference in market domination. Reed Hastings <a href="https://www.penguinrandomhouse.com/books/606529/no-rules-rules-by-reed-hastings-and-erin-meyer/"><em>No Rules Rules</em></a> is a game-changer about company culture in this regard. Indeed, a product is an item made in response to a pain point, created intentionally, and sustained and nourished through improvement over time. <strong><em>So what happens when it’s prioritized, especially for early-stage startups?</em></strong></p><p>In a tech setting, culture is linked <em>more directly to growth and scale. </em>In health tech specifically, a healthy culture conducive to high performance is perhaps more important, as the process of creating a product aimed at improving a consumer’s health, from a ‘toxic’ production line is likely to ripple out onto the product itself. For startups, culture impacts the ability to scale beyond Series A and therefore the difference between success and failure. Yet, it’s more nuanced when it comes to Big Tech, where it may primarily impact the launch of <em>new products</em>, but overall the impact on the company’s success is less profound once market domination is established. However, while market presence can sometimes buffer these firms from internal issues, maintaining a healthy culture remains beneficial, to support innovation and employee engagement.</p><h3><strong>The Case for Culture pre-Series C</strong></h3><p>Many Series A-funded companies, like <a href="https://www.reuters.com/article/technology/jawbones-demise-a-case-of-death-by-overfunding-in-silicon-valley-idUSKBN19V0BS/">Jawbone</a>, have faced, and continue to face, challenges progressing to Series B (and then C) funding, often due to complex internal dynamics (<a href="https://www.tactyqal.com/blog/why-did-jawbone-fail/">internal culture</a>). For other health tech startups, early (pre-Series B) acquisitions are needed to provide an alternative pathway for growth, highlighting the critical role that culture can play in supporting sustained progress through to IPO.</p><p>In the latter, such an <a href="https://sanfranciscopost.com/distressed-ma-acquiring-companies-in-financial-trouble/">acquisition </a>is often due to the inability to scale, a business model that eventually cannot keep up with the competition, or simply a mismatch between the executive teams’ experience (and competencies) from what’s required to move a startup through to Series B and beyond. In general, early acquisitions (“soft exit”) of startups once predicted to be winners (or even ‘unicorns’) for an undisclosed price is <a href="https://www.quora.com/I-sold-my-startup-just-before-it-went-bankrupt-it-was-mostly-a-talent-deal-The-investors-lost-half-of-their-money-How-do-I-talk-about-this-with-future-investors">concerning for financial distress,</a> as is a <a href="https://www.failory.com/startups/no-pivoting-failures">last-hour pivot</a> to other potential revenue streams just prior to the soft exit.</p><p>Yet, in very rare cases, culture has simply <em>nothing</em> to do with it: <a href="https://hbr.org/2021/01/why-haven-healthcare-failed">Haven</a> is a great example of this — at the time disrupting healthcare was simply too tough, <em>despite </em>a world-class founding team and reports around a great culture that fueled retention and high performance.</p><p><strong>Most startups fail</strong>, so it’s already a ‘bet’ to be a founder or an at-will employee of a startup (versus a more established legacy company). An <a href="https://techcrunch.com/2017/05/17/heres-how-likely-your-startup-is-to-get-acquired-at-any-stage">epidemiological survival curve</a> is helpful: it’s <em>extremely tough</em> to survive from seed to Series A, and arguably <em>statistically improbable</em> to survive beyond Series A. There’s an immense dropoff between Seed and Series A (60% fail before Series A) and then onto Series B (only about half of those that raise Series A move to Series B), and the proportion continues to shrink beyond this.</p><p>Moving from Seed to Series A requires a strong product, strong team (or at least a VC’s strong belief in the CEO), and traction/product-market fit.</p><p><strong><em>So where exactly does the culture of the company fit in?</em></strong></p><p><strong><em>Can it be considered a ‘product’ (even a ‘health product’) to cultivate as a ‘competitive edge,’ bucking the statistics around failure?</em></strong></p><p>Culture fits in most clearly for a startup to more seamlessly move from Series A to B, and in some cases Series B to C. We can presume that post-Series C, the company has <em>enough momentum/market traction</em> and <em>market dominance</em> that culture may play a <em>smaller role</em> — look to <a href="https://www.nytimes.com/2015/08/16/technology/inside-amazon-wrestling-big-ideas-in-a-bruising-workplace.html">Big Tech</a> for examples of this as well (very few consumers will stop using Amazon due to workplace culture complaints or even disagreeing with the founder, even if there <a href="https://www.axios.com/2024/10/30/washington-post-subscriber-cancellations-endorsements-bezos">may be</a> collateral damage). Companies like OpenAI, that are larger than Series A/B startups, but aren’t technically Big Tech legacy companies, may fall somewhere in the middle: the <a href="https://www.indiatoday.in/amp/technology/features/story/mira-murati-to-john-schulman-why-recent-leadership-exodus-at-openai-signals-bigger-problems-2609862-2024-10-02">swift exits of A-players is, naturally, concerning</a> but market domination, and Sam Altman’s focus to continue to retain <a href="https://www.businessinsider.com/sam-altmans-hiring-strategy-bets-on-talent-not-age-2024-11">A player talent,</a> including <a href="https://www.businessinsider.com/openai-hires-execs-leadership-positions-2024-10">in recent few weeks,</a> may play a larger role, placing this category of companies more squarely in the category of Big Tech as it relates to retention and culture (only time will tell).</p><p><strong><em>Culture isn’t a buzzword: </em></strong>it has nothing to do with surface-level ideas of ‘work-life balance,’ policies like unlimited PTO, or even the clichéd ping pong tables/breakrooms/free food. As a16z founder, Ben Horowitz shares: ‘it has <a href="https://a16z.com/programming-your-culture/">nothing to do with yoga or dogs at work</a>.’ Instead: it’s the backbone of a company’s performance and potential to beat the odds and push through from Series A to B, and onwards to Series C.</p><p>Recently, a<a href="https://fortune.com/article/tim-cook-apple-ceo-advice-hiring-qualities-recruiters-want-job-search/"> <em>Fortune</em> article </a>detailed how Tim Cook, CEO of Apple, prioritizes four qualities to ensure those he recruits for Apple succeed and help the company succeed: Expertise, Creativity, Collaboration, and Curiosity. Expertise must be the central hub, but the 3 ‘Cs’ are the spokes that make expertise actionable and adaptable, which are key for any startup.</p><p>Eric Schmidt (former Google CEO) takes <a href="https://www.instagram.com/reel/DAgPzr8qAB7/?igsh=MXFkY3ZteWRqOWwxMw==">this idea a step further</a>: A players have their quirks but they drive a culture of high performance; hire for ‘divas’ not ‘knaves.’ The former <em>‘believe in the company, drive people hard, expect a lot, and care passionately.’</em></p><p>These also happen to be classic “A player,” traits which help company’s create <a href="https://www.cnbc.com/2024/10/29/former-apple-exec-my-no-1-piece-of-advice-for-switching-industries.html">‘an entirely new framework’,</a> so optimizing for these traits, and <em>a culture </em>that fosters these traits is crucial. But what about the barriers to fostering such a culture?</p><p>This requires understanding both the dynamics and contributions (or lack thereof) of A, B, and C players in a startup (and how specifically C-players often derail growth), using tools like a premortem, and creating culture ‘checklists’ for funders (as part of due diligence) before funding a startup. These factors offer ways to prevent cultural pitfalls from becoming fatal, ultimately driving sustainable startup success.</p><h3>The A, B, and C Player Conundrum</h3><p>We can turn again to <a href="https://www.forbes.com/sites/maryjuetten/2019/02/05/failed-startups-jawbone/">Jawbone</a> as an example.</p><p>Many startups launch with a close-knit team of friends or acquaintances, but as growth demands more sophisticated talent, founders face a critical decision: identifying and cultivating A-level talent (those who have expertise, collaborative nature, creative, and curious, and often sought after by other team members for help, expertise and guidance). In fact, Todd Belveal <a href="https://medium.com/swlh/why-startup-founders-should-never-hire-their-friends-e79e53c66203">made a compelling case</a> for why a founder (the original founder, the one who first had the idea) should <em>not</em> hire their friends (even as co-founders):</p><p><a href="https://medium.com/swlh/why-startup-founders-should-never-hire-their-friends-e79e53c66203"><em>“Overvaluing people because of your relationship with them will cause problems down the road — both for you and your company.</em></a><em>”</em></p><p>It’s often the case that the original founder may then be stuck with the <a href="https://cjcornell.medium.com/the-startup-peter-principle-e891ca5a610c">Peter Principle</a>: co-founders or original employees who lack competence but possess power due to their longevity, who then stifle those <em>with</em> competence — the A-players.</p><p>So what about “A players” in a startup context? Are they born or shaped? The answer is most ‘arrive’ to a startup as an A-player — their track record of high performance shows it. As a founder, they can arrive <em>during</em> the Seed round if they guide strategy and are intrigued by the pain point. As an employee, they arrive typically <em>after the Seed round</em>, when funding provides a competitive salary (most A player employees will refuse ‘equity only’ approach namely as their skills give them choices around where to work). That said, some A-players can be shaped (from a B player) after the Seed round if they have the right support and the internal drive to be an A-player.</p><p>Often, early teams include B and, unfortunately, C-level players, who may <a href="https://cjcornell.medium.com/the-startup-peter-principle-e891ca5a610c">not be equipped</a> to navigate the complexities of scaling: in a startup, as <a href="https://cjcornell.medium.com/the-startup-peter-principle-e891ca5a610c">CJ Cornell</a> shares, where a founder cannot hire A players at the outset, primarily due to lack of funding, the ‘failure’ for C or B players to gain skills and competence (and ‘become’ an A-player) becomes a detriment:</p><p><em>“Popular startup wisdom says that startups should hire “A players” — the best of the best. But the majority of startups don’t have the resources to hire the best. And “the best” might not even exist. Many startups are working on breakthrough technologies, or inside emerging markets. They are creating new rules for new product categories, and they are understanding new customer behaviors in new markets. There are no experts yet; they must become the experts.”</em></p><p><a href="https://magmapartners.com/post/the-a-b-and-c-player-framework-helping-build-amazing-teams"><strong>This article</strong></a><strong>, by Magma Partners,</strong> dives deeply into distinguishing A players from B players and the dreaded C players. In summary, A players should be retained and supported, often given larger scope of responsibility (which they often take the initiative to take). C and C+ players should be exited, <em>regardless of how long they’ve been at the company,</em> as they fulfill only basic competencies and spend much of their working time destroying morale (e.g. gossip, manipulation, complaining, sabotage). Building a strong team often means evaluating alignment between each member’s strengths and the company’s evolving goals. C players often find it challenging to adapt to these changes, managers might consider a team structure that maximizes both morale and productivity. It’s indeed challenging to manage<a href="https://hbr.org/podcast/2024/11/how-do-i-deal-with-low-performers-on-my-team"> low performers</a> as there is often a significant skill and/or experience deficit.</p><p>B players, on the other hand, are tricky: some can be <em>shaped</em> into A players.</p><p><strong>Daniel Lok </strong><a href="https://danlok.com/why-b-players-are-dangerous-for-business/"><strong>has described</strong></a><strong> a phenomenon where some B players (whom he dubs ‘the Bare minimum players’) shouldn’t be ignored, </strong>as they repel A players if the B player’s abilities don’t meet the requirements needed for the next stage of growth. As one A player manager of a team at a Big Tech company described to me recently:</p><p><em>“I’ve learned to exit some B players because they drag down the A players if they’re threatened or worry the A player makes them ‘look bad.’ They don’t want to work as hard as the A players but they also want the steady paycheck, so their strategy is to pull the A players down covertly before a manager puts their own job at risk. So we restructure a team or vertical so that B player is redundant.”</em></p><p>If not managed well, these C player team members, and certain B player team members, can foster a competitive, even hostile, environment that stifles innovation and deters A-level performers from staying. Individuals with hostile personalities or disorders can exacerbate toxicity, leading to a work culture plagued by envy, resentment, and unnecessary competition. These team dynamics can become challenging, potentially creating an environment that may feel competitive or counterproductive. Supporting collaboration and encouraging open dialogue can be powerful tools in fostering a culture that retains high performers. Again, we can look at <a href="https://www.theinformation.com/articles/what-went-wrong-at-jawbone">Jawbone </a>as falling prey to some of these dynamics.</p><h3>Hostile Personalities/Personality Disorders and C-players</h3><p><strong>In a recent </strong><a href="https://www.hubermanlab.com/episode/bill-eddy-how-to-deal-with-high-conflict-people"><strong>Andrew Huberman podcast</strong></a>, featuring legal expert (and therapist) Bill Eddy, the distinction is made between hostile personalities and the traits of those with<a href="https://www.psychologytoday.com/us/blog/the-discomfort-zone/202402/navigating-borderline-personality-disorder-in-the-workplace"> borderline personality disorder/BPD</a> (and in some instances <a href="https://www.psychologytoday.com/us/blog/the-narcissist-in-your-life/202007/52-ways-to-identify-a-covert-narcissist">convert narcissists</a> — those who appear humble but overlap more with BPD).</p><p>This can be seen in various industries that involve teams, including professional sports: as football coach Nick Saban <a href="https://www.instagram.com/reel/C-mArtyN391/?igsh=anR4bG4xd250MTI1">says quite simply</a>, fostering a culture where everyone aligns with high standards can enhance team performance and help retain high achievers:</p><p><em>‘mediocre people don’t like high achievers, so if everyone doesn’t buy-in to the same high standard, you’ll never be successful.’</em></p><p>When team members share a commitment to excellence, it strengthens the foundation for growth.</p><p>In a startup context, there’s a spectrum between hostile personality behavior and florid personality disorder behavior, and these behaviors are <strong><em>almost always observed in low-performing/less competent C players</em></strong> <strong><em>(and less self-assured B-players)</em></strong>. In contrast, more collaborative behavior is more common among <strong><em>fellow A-players or more competent/more self-assured B-players.</em></strong></p><p>A clear example, focusing on behavior ‘towards’ high-performing team members is shown in the table below. ‘Hostile’ behavior towards an “A player” (or solid B player), which originates from a lower performer’s resentment and insecurity, is seen in the ‘negative view’ below, compared with ‘positive view’ below, which originates from a high performer’s own self-awareness and self-confidence:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Oi6yCsmtn10lcjf2MT07_w.png" /><figcaption>“Hostile” (negative view) perceptions of A-players among primarily C-players, vs a “Collaborative” (positive view”) perceptions among fellow A-players</figcaption></figure><p>However, as it relates to those Eddy describes with a <strong><em>florid personality disorder:</em></strong> these are team members who have often emit the lion&#39;s share of gossip, complaining, often <em>play the victim</em> the most, are <em>triggered</em> by the smallest of slights (and most often triggered by things in their imagination) or simply by an <em>overwhelming sense of envy or jealousy</em> at another team member’s abilities. They likely ‘coast’ through the day, clock in and clock out, and have limited skills (are usually in the bottom 10% in their field — chosen primarily out of <a href="https://medium.com/swlh/why-startup-founders-should-never-hire-their-friends-e79e53c66203">convenience</a> at an early startup stage or, in rare cases, because they’ve overstated their experience and abilities). In other words, these traits may help <a href="https://magmapartners.com/post/the-a-b-and-c-player-framework-helping-build-amazing-teams"><em>explain</em> the behavior</a> of C-players.</p><p>Encouraging a culture of psychological safety, where everyone feels comfortable sharing concerns <em>constructively</em>, can help mitigate these behaviors, and foster a more positive atmosphere.</p><p><strong>The most dangerous element Huberman and Eddy describe, which can derail an early-stage startup, is what’s called “</strong><a href="https://www.psychologytoday.com/us/blog/5-types-people-who-can-ruin-your-life/201803/are-you-target-blame-borderline-personality"><strong>negative advocacy</strong></a><strong>:”</strong> when a BPD individual, who <a href="https://www.verywellmind.com/borderline-personality-disorder-identity-issues-425488">lacks a stable sense of self</a>, using their emotional reactions against someone perceived as a threat (it could be a team member or manager) and then shares that reaction incessantly with others to manipulate them into shifting their view from ‘positive’ to ‘negative’ (as in the table above).</p><p>Emotions are contagious, Eddy describes, and, in a compelling story where one of his clients was accused of illegal and unethical behavior by a BPD ex-wife, can cause lasting damage. <em>Note:</em> often this ‘negative advocacy’ can be framed as the BPD-leaning C-player labeling (to those they can manipulate) the high-performing A-player as ‘not collaborative’, ‘micromanaging,’ or other descriptors to downplay true collaborative, high-performance behavior — all aspects described in the table as a ‘lens’ in which they view those they perceive as threats.</p><p>The solution (according to Eddy): when a BPD/covert narcissist team member, who is often a C player, engages in hostile behavior simply <strong><em>ask for data and evidence (to back up anything that appears personal, gossip, etc). </em></strong>As well, Eddy advises ‘not labeling’ a BPD-er (or, for that matter, a convert narcissist) to them, but simply <em>being aware, document, adapt to it as much as possible, and then lean on the right processes to ensure accountability</em>. This, again, is due to the <a href="https://www.verywellmind.com/borderline-personality-disorder-identity-issues-425488">unstable sense of self </a>and likelihood of triggering a BPD individual severely that they lash out in a way that can cause immense harm.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/1*8D5J78KtlS9XdPom2v70hQ.jpeg" /><figcaption>Some have depicted gossip, complaining, excuse-making as a lower self vs higher self dichotomy, and how brain wiring, and one’s experience of reality may both impact and be influenced by these behaviors</figcaption></figure><p>In a startup context, a robust process, with data and evidence, remain cornerstones of deciphering truth from manipulation. This again is why data, evidence (feedback from direct reports, performance metrics) matters — it provides the CEO, who is driven to ensure the startup performs and remains accountable to investors, the power to discern fact from fiction and let this information guide decisions. As renowned workplace culture expert, Cy Wakeman often describes, there is a<a href="https://realitybasedleadership.com/the-cost-of-drama/"> ‘cost’ </a>to drama in organizations.</p><p>Notably Eddy clarifies that, despite perceptions, Steve Jobs was <em>less</em> likely to have a personality disorder, given his desire for a flat hierarchy, ongoing feedback on products, and so forth. Indeed, it’s possible that most of the ire may have arrived from C and B player team members who struggled with <a href="https://www.instagram.com/reel/C_IbmBuMvB4/?igsh=NHJ5OXhiNnQ5NGcw">Jobs’ expectations and vision</a>.</p><p>It’s also worth stating plainly that some A-players are, as Stanford’s Bob Sutton <a href="https://hbr.org/2007/03/why-i-wrote-the-no-asshole-rule">explains</a>, truly challenging, truly not collaborative, and highly ego-driven. In some instances, they may be <a href="https://www.psychologytoday.com/us/blog/neurosagacity/201702/how-tell-youre-dealing-malignant-narcissist">malignant narcissists</a>, sharing with covert narcissists and BPD team members characteristics such as an unstable sense of self and dependency on validation, on top of a fear of abandonment and a tendency towards jealousy. The key to identifying them, over the ones merely mislabeled as such, is by speaking directly to direct reports, and asking for evidence of a lack of collaboration. A simpler approach may be to use what Adam Grant describes as ‘<a href="https://hbr.org/2013/04/in-the-company-of-givers-and-takers">givers and takers</a>’ — — the ‘giver’ or ‘generous’ A players are those that perform highly and are committed to ensuring their team is supported so that they perform highly; a ‘taker’ or ‘uncollaborative’ A player is one that focuses purely on their own performance (and taking credit for the work of others) and their own gain (see <a href="https://www.instagram.com/reel/DAgPzr8qAB7/?igsh=MXFkY3ZteWRqOWwxMw==">the example</a> of ‘knaves’ according to Eric Schmidt).</p><p>Recognizing these dynamics early on and encouraging open communication can help foster a collaborative, inclusive work culture.</p><h3>Data-Driven Decision-Making for A-player Retention</h3><p>Indeed, to retain top talent, i.e. the ‘giver’ form of A players, founders must commit to <strong>data-driven decision-making.</strong> By triangulating feedback and hard data, companies can see past personal agendas, recognizing and rewarding those who contribute meaningfully. As well, adopting Harvard Business School’s Dr. Amy Edmonson’s concept of <a href="https://hbr.org/2023/02/what-is-psychological-safety">psychological safety</a> is crucial: allowing those with integrity and honesty to speak up honestly about the issues without fear of repercussions.</p><p><strong>A dangerous combination: <em>low </em>psychological safety (high integrity, high-performance team members<em> not</em> being able to speak up safely) and <em>high</em> hostility (influence via negative advocacy from the most problematic C-players). </strong>Being aware of <a href="https://www.verywellmind.com/protecting-yourself-from-darvo-abusive-behavior-7562730">DARVO is also key </a>(the A-player may defend themselves but, if the BPD/narcissist is successful in their <a href="https://psychcentral.com/blog/recovering-narcissist/2017/07/3-sneaky-techniques-covert-narcissists-use-to-disarm-and-demean-you#1">manipulation</a>, in a culture of low psychological safety it is unlikely to help and may even result in the A-player leaving for a healthier company).</p><p><strong>Reversing this deadly combination:</strong> investing in high psychological safety but keeping C-players accountable (and ideally exiting them swiftly) improves culture but also ensures a foundation that allows growth and adaptability, especially as a startup seeks to reach the contingent funding milestones VCs backing a Series A or B investment require. When team members bring up concerns, especially those that may appear rooted in personal perceptions, it’s helpful to focus on data and clear examples. This ensures that feedback remains constructive and centered on actionable insights, supporting a transparent and positive work environment.</p><p>Again, a caveat: Post Series C, culture <em>may not play as large of a role.</em> Certainly, A-players are needed for internal innovation (see: Steve Jobs or Jony Ive at Apple; Elon Musk at Tesla) to drive success, but the majority of a company may indeed be comprised strong B-players that simply help maintain the momentum fueled by A-players, by delivering existing products on time, and collaborate effectively within the processes created most often by A players (even if the B-players aren’t usually directly driving metrics or new products nor processes).</p><h3>The Venture Capital Checklist</h3><p>For venture capitalists, supporting a startup’s cultural development can be as impactful as providing financial backing. By fostering open discussions around team cohesion and culture, VCs can strengthen their partnership with founders and contribute to the company’s resilience. <br>[Note: <a href="https://medium.com/@amithakalaichandran/iterating-on-the-due-diligence-process-in-healthtech-vc-f233c5b11f86">Here</a> is an adapted DD framework that may be useful for tech/healthtech]</p><p>I’ve had several discussions with top VCs that led me to this concept: so often VC firms are faced with the challenge of cofounder infighting, low retention of high performers, and ultimately lackluster metrics which signal a hasty investment in a company bound to fail. When I’ve asked them how they may approach ‘fixing culture,’ <em>before</em> impending failure, the most common response is: ‘it’s too difficult to change culture from the outside, so we stay out of it unless asked directly to help transition out a cofounder.’ In other words: VCs most often cut their losses and rely on the <a href="https://medium.com/leadership-prevails/understanding-the-vc-power-law-why-fund-size-matters-in-venture-capital-returns-b3dcc2681509#:~:text=Power%20Law%20returns%20graph%20based,losses%20of%20many%20unsuccessful%20ones.">Power Law</a>.</p><p>But what if there were more robust vetting <em>prior</em> to the investment? Thorough background checks of all founders are key, as are interviews with former colleagues, and a review of team experience and cohesion should be part of every investor’s due diligence. One VC firm shared that, while this is their process, most firms (even large ones) have a tendency to complete the most rigorous background and reference checks on the CEO founder as the standard, which then affords trust in the CEO’s choices for cofounders and other leaders (“We believe in the CEO cofounder, and therefore believe in the CEO’s choices”). Of the large firms, there’s a level of heterogeneity there: the partners most likely to have the greatest returns are the ones who are more rigorous in their vetting of the founding team (even making suggestions for ‘swaps’ to ensure the CEO’s success).</p><p>By understanding the company’s culture, venture capitalists can gauge whether the team has a foundation strong enough to withstand rapid scaling and market pressures. <strong>Completing as rigorous of a process on the other cofounders is key</strong>: all cofounders must either be A-players or strong B-players, as evidenced by prior accomplishments and successes (formal training may play a role as well, especially if that training is helpful to a managerial, financial, or operations role).</p><p>One venture capital partner shared that a strong founding team is essential to startup success, as each cofounder’s strengths and commitment can shape team dynamics and long-term retention of top talent. Ensuring alignment and a shared vision among cofounders supports resilience through early challenges. They shared that, in their experience, if <em>just one cofounder is a C-player</em>, it greatly impedes success, even if only by impacting the retention of A-player employees (who drive performance metrics) in the company at large.</p><p>This assessment goes beyond financial metrics; it’s about securing a foundation for long-term (post-Series A/B) success. In early funding rounds, contingencies based on performance metrics are common, and companies with a culture of transparency, accountability, and collaboration are better equipped to meet these goals. For both founders and investors, a supportive, resilient culture can be the determining factor in achieving sustainable growth, <em>particularly before Series C.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/960/1*yFQMcBUltpyzPK1W7XXRzQ.jpeg" /><figcaption>Credit: @VisualHustles</figcaption></figure><h3>The Power of a Premortem for Identifying (&amp; Addressing) Cultural Red Flags</h3><p>Enter the<a href="https://www.tugboatinstitute.com/the-pre-mortem/"> premortem</a>, a strategy introduced by Daniel Pink that asks teams to imagine their company has already failed and then work backward to uncover the reasons why. A premortem offers a proactive approach to assess potential areas of improvement, allowing teams to address them before they become obstacles. Regular premortems encourage leaders to consider blind spots, communication breakdowns, and imbalances in workload — all of which can quietly sabotage growth if left unchecked. Premortems provide leaders with a process that can help strengthen team cohesion and align everyone toward shared goals.</p><p>For instance, leadership conflicts played a significant role in Jawbone’s decline. By conducting premortems, Jawbone might have spotted these tensions early and addressed them, fostering a culture of collaboration rather than one of internal competition. From improved communication to fair workload distribution, a premortem gives founders and leadership teams a proactive way to nurture a culture that aligns with long-term goals.</p><p>Culture can indeed be a silent killer in startups, and can be particularly challenging in a startup dedicated to creating a health tech product (the dissonance of creating something ‘for health’ from a place of ‘illness/toxicity’). Toxicity often goes unnoticed until it’s too late, quietly eroding morale, productivity, and retention. To prevent this, founders and venture capitalists must invest in cultural health checks that reveal any underlying interpersonal issues or gaps in leadership transparency.</p><p>Companies with healthy, inclusive (and high psychological safety) environments are more likely to retain top talent and inspire loyalty, fueling growth and resilience through both challenges and successes. This then leads quite readily to creating great products, iterating swiftly on old products, and staying ahead of the competition to dominate the market and continue delivering value and impact to consumers/users.</p><p>In <a href="https://www.dice.com/career-advice/lessons-jawbone-failures">Jawbone’s</a> case, an early cultural health check could have prompted leadership to address emerging tensions, creating a strategy to sustain team cohesion and then iterate quickly to improve existing products and gain market share over competitors (e.g. Fitbit). By recognizing potential cultural issues, the company could have <a href="https://www.vox.com/2016/1/15/11588846/as-sameer-samat-heads-back-to-google-jawbone-gets-165m-in-funding-in">retained its top talent</a> (and investors) and fostered a sense of unity that would have supported its scaling efforts.</p><h3>A Culture “Health Check” for Founders &amp; Investors</h3><p><strong>1. Conduct Regular Premortems</strong>: Simulate future failures of both the company and work backward to understand the causes. Involve the team and, if possible, external advisors who can provide an unbiased perspective. Use the same strategy to imagine a failure of retention: identify the top 10% of high performers who are driving 90% of the results and imagine they’re recruited elsewhere or resign. Then ask ‘why,’ and make the shifts necessary to lower that risk. Reed Hastings encourages his A-players to speak with recruiters, for instance, and then aims to top out the offer A-players share as an effort to reduce the risk of top performer resignations or competitor poaching.</p><p>These proactive strategies helps identify weaknesses before they become existential threats. It’s a small investment at the outset that can reap dividends over the long-term.</p><p><strong>2. Invest in Culture as “organizational health”</strong>: Just as you would track financial health, invest in understanding and improving your team’s cultural dynamics. Most of this involves<a href="https://www.linkedin.com/posts/infographic-insights_5-signs-of-a-high-performing-team-credit-activity-7259489639772626945-1iZD?utm_source=share&amp;utm_medium=member_desktop"> low-tech approaches:</a> role clarity, open communication, and methods to increase trust and safety are key. Establish measurable goals, and ensure your company’s culture remains resilient and adaptive as it grows. As a bonus: high-performance team members that feel ‘well’ and ‘thrive’ are more likely to stay, and continue to overperform and overdeliver, fueling performance metrics that your investors care most about and products your customers continue to love.</p><p><strong>3. Recruit, Retain. and Value A-Level Talent; swiftly identify and exit the C-Level talent; assess the B-Level talent</strong>: Conduct objective performance reviews, paying close attention to KPIs, OKRs, and the contributions to each by various team members. High-performing employees are essential to a startup’s success. Foster a culture where A-level talent feels supported, valued, and empowered. To borrow from <a href="https://www.businessinsider.com/sam-altmans-hiring-strategy-bets-on-talent-not-age-2024-11">Sam Altman</a>’s hiring approach: talent and competence reign over other factors (e.g. age) in a fast-moving industry.</p><p><a href="https://magmapartners.com/post/the-a-b-and-c-player-framework-helping-build-amazing-teams">Identify the C-Level talent</a> by noticing ‘negative advocacy’ and a disconnect between the ‘complainers’ and the ‘competent.’ A rule of thumb: if a team member complains incessantly about another, first assess if there’s a marked <strong><em>gradient in competence: </em></strong>If the complainer is a C-level player complaining about a B+ or A player, it’s <strong><em>likely</em></strong><em> fueled by a sense of threat and the motivation to retain their role through nefarious behavior. </em>While you cannot ‘diagnose’ <a href="https://www.verywellmind.com/what-is-borderline-personality-disorder-bpd-425487">BPD</a> or <a href="https://www.calm.com/blog/covert-narcissist">covert narcissism</a>, you <em>can</em> spot patterns and, as Bill Eddy advises, note the <em>disconnect</em> between their complaints and the evidence.</p><p>By focusing on each team member’s strengths and growth areas, companies can foster a culture that aligns with their goals while encouraging team morale. When difficult interactions arise, it can be helpful to focus on facts and specific examples to ensure productive communication. Encouraging transparency and grounding feedback in concrete data can reinforce a collaborative environment where concerns are addressed fairly.</p><p>This investment pays dividends in loyalty, innovation, and productivity, which then fuels high performance, growth and scale. <a href="https://danlok.com/why-b-players-are-dangerous-for-business/">For B-level talent,</a> assess <em>who</em> can be shaped into A-level talent with the right support, and who may be teetering on C-level. A starting point: evaluate how B-level talent perceives A-players — if they hold a ‘positive view’ (as per the table) it’s likely they see A-player performance as motivational, if they hold a ‘negative view,’ they’re likely threatened, and will move down a rung into C-level performance as the startup grows and as performance expectations become higher.</p><p><strong>4. Extend Due Diligence Beyond Financials</strong>: Investors typically care most about <a href="https://articles.sequoiacap.com/retention">product retention,</a> however employee retention is also key. As such, investors should assess team dynamics, leadership cohesion, and other aspects of culture — all elements that require rigorous evaluation and triangulation of all founders (not just the CEO). As <a href="https://a16z.com/hiring-a-chief-operating-officer/">a16z </a>(and analyzed in <a href="https://www.forbes.com/sites/bradsvrluga/2013/07/24/the-myth-of-the-startup-coo/"><em>Forbes</em></a>) have written, some roles in the C-suite may <em>not</em> in fact be needed at an early stage where founder-role experience/expertise fit matters most; however some (e.g. <a href="https://a16z.com/why-we-prefer-founding-ceos/">a CEO founder</a>) do provide an edge. Investors can play a key role in identifying key processes and policies (e.g. <a href="https://www.sequoia.com/2024/02/how-to-use-equity-to-retain-and-recruit-top-talent/">higher than standard equity</a>) to foster a healthy culture conducive to high performance and ‘<a href="https://a16z.com/the-techno-optimist-manifesto/">techno optimists</a>.’ A company’s ability to scale relies heavily on a foundation of trust, collaboration, and transparency. Regular check-ins and assessments, especially via evaluating the association between team performance metrics and team leadership is key.</p><h3>The Bottom Line</h3><p>Culture is complex, but one thing is clear: a healthy, transparent, and inclusive environment conducive to high performance is essential for long-term health tech startup success, particularly at the Series A and Series B stage. While hospitals are impacted by culture through low healthcare provider retention and poor patient outcomes, health tech startups may suffer from the inability to grow/scale and dominate the market (thus failing well before Series C).</p><p>Jawbone offers many lessons in this regard. While Jawbone failed before Series B, their closest competitor, Fitbit, grew, and obtained an <a href="https://www.forbes.com/sites/davidphelan/2019/11/01/google-buys-fitbit-for-21-billion-heres-what-it-means/">impressive acquisition</a> ($2.1B!). Companies that prioritize building a high-performance culture will retain their best talent and position themselves to thrive in an increasingly competitive landscape. By blending proactive premortem practices with ongoing cultural health checks, founders and investors can prevent internal issues from escalating, ensuring their ventures grow not only in size but in resilience.</p><p>Founders and investors must stay vigilant, fostering environments where A-level talent can flourish securing lasting success, and may be summed up as:</p><p><strong><em>(i) Post-Series ‘A,’ use this infusion of capital to invest in recruiting and retaining ‘A’-players in this ‘building/growth phase’, swiftly exit remaining C-players and replace with A players or strong B players.</em></strong></p><p><strong><em>(ii) Entering Series B: strong B-players will be the backbone to maintain momentum, continuing the work of A-players; exit any B players whose abilities are a mismatch for expectations and who may thus become C players (impacting morale and thus momentum). Provide A-players a wider scope of responsibilities and work on retaining them/reducing the risk of competitor poaching.</em></strong></p><p><strong><em>(iii) Series C onwards: culture matters less if market domination is maintained and with an A-player CEO and COO at the helm driving strategy and direction (held accountable by, and/or recruited by, the Investor Board), as C players are unlikely to be recruited and onboarded at this phase.</em></strong></p><p>Companies that succeed in being first movers, and differentiators, and create a Reed Hastings-like culture are rare but powerful, much like Netflix. The intentional design of culture as a product can be the secret sauce that propels tech companies to market domination. In today’s health tech startup ecosystem, innovation and business models are crucial, but it’s the <em>unseen cultural forces</em> that truly shape a company’s trajectory.</p><p>“<a href="https://a16z.com/podcast/culture-as-code/">Culture is Code</a>.” Fortunately, factors that impact the retention of collaborative high performers during a key growth and building phase place culture as a secondary ‘health product,’ that can potentially be <a href="https://a16z.com/programming-your-culture/">programmed</a> with the right framework, driving growth, scale, and ultimately <strong><em>impact.<br>[if you’ve read this far, congrats. A shorter part 2, based on a key omission identified by an exec coach, can be found </em></strong><a href="https://amithakalaichandran.medium.com/culture-as-a-product-redux-why-on-running-succeeded-3f89691a25a8"><strong><em>here</em></strong></a><strong><em>]</em></strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=88d6a82a49b6" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Sensing the Sublime]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://amithakalaichandran.medium.com/sensing-the-sublime-6d186c323943?source=rss-f0aa9a2e29a0------2"><img src="https://cdn-images-1.medium.com/max/1920/1*CWQlY-o9uY785aPtWxqusA.png" width="1920"></a></p><p class="medium-feed-snippet">The power of exploring the sublime to journey beyond the ordinary.</p><p class="medium-feed-link"><a href="https://amithakalaichandran.medium.com/sensing-the-sublime-6d186c323943?source=rss-f0aa9a2e29a0------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://amithakalaichandran.medium.com/sensing-the-sublime-6d186c323943?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/6d186c323943</guid>
            <category><![CDATA[new-years-resolutions]]></category>
            <category><![CDATA[spirituality]]></category>
            <category><![CDATA[new-year]]></category>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Sun, 14 Jan 2024 14:36:54 GMT</pubDate>
            <atom:updated>2024-01-14T14:36:54.008Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[From HLTH2023: 3 Companies that are Leading the Charge in Tech Meets Wellness]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://amithakalaichandran.medium.com/from-hlth2023-3-companies-that-are-leading-the-charge-in-tech-meets-wellness-2c75d069605f?source=rss-f0aa9a2e29a0------2"><img src="https://cdn-images-1.medium.com/max/854/1*fGyTCEL9ptutCvNU_zojIQ.jpeg" width="854"></a></p><p class="medium-feed-snippet">HLTH 2023, the most prominent global conference dedicated to health tech, held its largest-ever conference earlier this month in Las Vegas&#x2026;</p><p class="medium-feed-link"><a href="https://amithakalaichandran.medium.com/from-hlth2023-3-companies-that-are-leading-the-charge-in-tech-meets-wellness-2c75d069605f?source=rss-f0aa9a2e29a0------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://amithakalaichandran.medium.com/from-hlth2023-3-companies-that-are-leading-the-charge-in-tech-meets-wellness-2c75d069605f?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/2c75d069605f</guid>
            <category><![CDATA[health-tech-trends]]></category>
            <category><![CDATA[headspace]]></category>
            <category><![CDATA[oura]]></category>
            <category><![CDATA[prenuvo]]></category>
            <category><![CDATA[healthtech]]></category>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Sat, 28 Oct 2023 19:59:59 GMT</pubDate>
            <atom:updated>2023-11-02T01:46:37.127Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[On Mirrors, Teachers, Expanders]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://amithakalaichandran.medium.com/on-mirrors-teachers-expanders-d66c2fb2aab8?source=rss-f0aa9a2e29a0------2"><img src="https://cdn-images-1.medium.com/max/2100/1*3ukHI1SkHHJFipIbLHYKTQ.jpeg" width="2100"></a></p><p class="medium-feed-snippet">I don&#x2019;t often (or ever!) write about spiritual elements of health and healing (not to mention ideas with no references or &#x2018;reporting&#x2019; per&#x2026;</p><p class="medium-feed-link"><a href="https://amithakalaichandran.medium.com/on-mirrors-teachers-expanders-d66c2fb2aab8?source=rss-f0aa9a2e29a0------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://amithakalaichandran.medium.com/on-mirrors-teachers-expanders-d66c2fb2aab8?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/d66c2fb2aab8</guid>
            <category><![CDATA[mindfulness]]></category>
            <category><![CDATA[relationships]]></category>
            <category><![CDATA[friendship]]></category>
            <category><![CDATA[boundaries]]></category>
            <category><![CDATA[psychology]]></category>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Fri, 11 Aug 2023 02:07:50 GMT</pubDate>
            <atom:updated>2023-08-18T19:40:58.038Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Shades of Gray: Towards a New Way of Categorizing Psychiatric Illness]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://amithakalaichandran.medium.com/shades-of-gray-towards-a-new-way-of-categorizing-psychiatric-illness-e3bef5254303?source=rss-f0aa9a2e29a0------2"><img src="https://cdn-images-1.medium.com/max/2600/1*m5GpGs69Aoj_0nF6Zn5Pkg.jpeg" width="3500"></a></p><p class="medium-feed-snippet">A new crop of researchers hope that computational psychiatry will shift how we understand the mind, which could lead to novel ways to&#x2026;</p><p class="medium-feed-link"><a href="https://amithakalaichandran.medium.com/shades-of-gray-towards-a-new-way-of-categorizing-psychiatric-illness-e3bef5254303?source=rss-f0aa9a2e29a0------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://amithakalaichandran.medium.com/shades-of-gray-towards-a-new-way-of-categorizing-psychiatric-illness-e3bef5254303?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/e3bef5254303</guid>
            <category><![CDATA[psychiatry]]></category>
            <category><![CDATA[neuroscience]]></category>
            <category><![CDATA[mental-health]]></category>
            <category><![CDATA[psychology]]></category>
            <category><![CDATA[medicine]]></category>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Tue, 02 Aug 2022 14:36:49 GMT</pubDate>
            <atom:updated>2022-08-15T08:22:35.516Z</atom:updated>
        </item>
        <item>
            <title><![CDATA[Musings on value-based care (as a Canadian)]]></title>
            <description><![CDATA[<div class="medium-feed-item"><p class="medium-feed-image"><a href="https://amithakalaichandran.medium.com/musings-on-value-based-care-as-a-canadian-23d4042084fa?source=rss-f0aa9a2e29a0------2"><img src="https://cdn-images-1.medium.com/max/600/1*KTOpk7-jZyuNrEFi999KRA.jpeg" width="600"></a></p><p class="medium-feed-snippet">Value-based care is one of the most crucial concepts in healthcare today, in both the US and Canada.</p><p class="medium-feed-link"><a href="https://amithakalaichandran.medium.com/musings-on-value-based-care-as-a-canadian-23d4042084fa?source=rss-f0aa9a2e29a0------2">Continue reading on Medium »</a></p></div>]]></description>
            <link>https://amithakalaichandran.medium.com/musings-on-value-based-care-as-a-canadian-23d4042084fa?source=rss-f0aa9a2e29a0------2</link>
            <guid isPermaLink="false">https://medium.com/p/23d4042084fa</guid>
            <category><![CDATA[medicine]]></category>
            <category><![CDATA[public-health]]></category>
            <category><![CDATA[health-policy]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[value-based-care]]></category>
            <dc:creator><![CDATA[Amitha Kalaichandran]]></dc:creator>
            <pubDate>Wed, 02 Mar 2022 11:26:51 GMT</pubDate>
            <atom:updated>2022-03-02T11:53:27.587Z</atom:updated>
        </item>
    </channel>
</rss>